| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Alphatec Holdings, Inc.$8.67
+0.41 (+4.96%)
F 17Pipeline Score MedTech · Commercial
Market Cap
1.15 B
EPS
-0.83
P/E Ratio
-9.05 $
Value Trade
18.48 M
SEC Financials
Q1 2026Dilution Risk
Revenue
192.11 M
R&D Expenses
17.56 M
Operating CF
1.29 M
Total Assets
799.48 M
Total Liabilities
799.48 M
Equity
-5.35 M
D/E Ratio
12,345
8.96 %
Week
-21.46 %
1 Month
-39.33 %
3 Month
-57.65 %
6 Month
-45.91 %
5 Year
-92.35 %
All Time
Cash Data
Cash Position
139.91 M
Monthly Burn
-
Runway
12,345 mo
Burn Trend
StableSEC Filing
May 5, 2026
Overview
Volume
1.79 M
52 Week Range
6.82 - 23.29
% held by Insiders
21.29 %
% held by Institutions
76.16 %
Enterprise Value
1.64 B
Total Shares
151.44 M
Short %
11.96 %
Float Shares
114.94 M
Company Description
locked
Upcoming Catalyst
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
Drug Pipeline Intelligence
F17
Pipeline Score -
Pipeline ValueValuation Signal
0
Drugs Scored—
rNPV / MCap Top 17%
Micro Cap (rank 759 of 913)
Percentile RankAlphatec Holdings, Inc. has significant pipeline risk (17/100).
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in ATEC
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
ATEC Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-08-21 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-08-21 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-08-21 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
ATEC▲ +5%today
ATEC Announces Participation in Upcoming Investor Conferences
Alphatec Holdings, Inc. (ATEC) has announced its participation in upcoming investor conferences. The company will host one-on-one meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 10, 2026, and will present at the 19th Annual Piper Sandler MedTech conference. This engagement reflects ATEC's commitment to investor relations.
Read more →ATECATEC to Report Second Quarter 2026 Financial Results on August 4, 2026
Alphatec Holdings, Inc. (ATEC) will report its second quarter 2026 financial results on August 4, 2026, after market close. The company is dedicated to innovative solutions in spine surgery. A live webcast will be held at 1:30 p.m. PT / 4:30 p.m. ET to discuss the results.
Read more →ATECALPHATEC INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Alphatec Holdings, Inc. on Behalf of Alphatec Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. is investigating potential claims against Alphatec Holdings, Inc. on behalf of stockholders following the company's disappointing first-quarter financial results for 2026. The investigation arises from a reported revenue miss and a reduction in the company's yearly outlook due to challenges in installation timing and unmet delivery commitments. This news has led to a decline in Alphatec's stock price, prompting the law firm to encourage affected investors to explore their legal options.
Read more →ATEC▼ -31.7%on this news
Alphatec Holdings, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Johnson Fistel, PLLP is investigating potential claims for investors of Alphatec Holdings, Inc. after the company reported disappointing first quarter 2026 financial results. The investigation centers on whether Alphatec's executive officers misled investors regarding the company's performance, particularly concerning lower-than-expected EOS sales and execution challenges. As a result, Alphatec has revised its EOS revenue outlook for the year downward. The news has led to a significant decline in the company's stock price, prompting Johnson Fistel to encourage affected investors to seek assistance.
Read more →ATECATEC Refinances Existing Debt with Inaugural Bank Facility
ATEC has announced the refinancing of its existing debt through a new bank facility. This marks the company's inaugural engagement with a bank for such financing. The move aims to improve ATEC's financial flexibility and support its operational goals.
Read more →ATECATEC Reports First Quarter Financial Results
ATEC has released its financial results for the first quarter. The report includes various metrics and figures that reflect the company's performance during this period. However, specific details about revenue, expenses, or future projections were not disclosed in the article.
Read more →ATECATEC to Report First Quarter 2026 Financial Results on May 5, 2026
Alphatec Holdings, Inc. (ATEC) will report its first quarter 2026 financial results on May 5, 2026, after market close. A live webcast will be held at 1:30 p.m. PT, and analysts must register in advance for the Q&A session. Additionally, ATEC will participate in the Bank of America Securities 2026 Healthcare Conference on May 12.
Read more →ATEC▲ +5.9%on this news
ATEC Reports Fourth Quarter and Full-Year 2025 Financial Results Full-year 2025 total revenue grew 25% to $764 million, enabling significant profit margin expansion Full-year 2026 total revenue expected to approximate $8
Alphatec Holdings, Inc. (ATEC) reported its financial results for the fourth quarter and full year 2025, highlighting a 25% increase in total revenue to $764 million. The company achieved a significant profit margin expansion and expects total revenue for 2026 to approximate $890 million. Despite a GAAP net loss of $143 million for 2025, ATEC reported positive free cash flow in the fourth quarter and projects continued growth with expected adjusted EBITDA of approximately $134 million for 2026. The report also details the launch of their Valence intraoperative platform and implications for future performance.
Read more →ATEC▼ -6.5%on this news
ATEC and Theradaptive Enter Strategic Partnership for Breakthrough Regenerative Technology in Spinal Fusion
Alphatec Holdings, Inc. (ATEC) has entered a strategic partnership with Theradaptive, gaining exclusive U.S. rights to the OsteoAdapt platform for spinal fusion. This collaboration aims to enhance the efficacy of spinal surgeries through innovative regenerative medicine. Theradaptive is also initiating a Series B funding round to support clinical studies and commercialization efforts.
Read more →ATEC▼ -22.3%on this newsshared move
ATEC Announces Select Preliminary Financial Results for 2025 and Provides 2026 Outlook Full-year 2025 total revenue grew 25% to approximately $764 million Expect full-year 2026 total revenue of $890 million
Alphatec Holdings, Inc. (ATEC) announced preliminary financial results for 2025, highlighting a total revenue increase of 25% to approximately $764 million. The company anticipates a further revenue growth to $890 million in 2026, driven by strong surgical revenue performance. Additionally, ATEC has secured exclusive U.S. distribution rights for Theradaptive's next-generation rhBMP-2 solution, OsteoAdapt. This acquisition aims to enhance the company's procedural offerings in spinal health, addressing challenges in the market concentration of biologics.
Read more →ATECATEC Mourns Passing of Board Member Jeffrey P. Rydin
Alphatec Holdings, Inc. announced the passing of Board member Jeffrey P. Rydin at the age of 59 due to a lengthy illness. Rydin was a crucial figure in ATEC's turnaround efforts, having joined the Board in 2017 and significantly influenced its strategic decisions. CEO Pat Miles expressed deep sorrow over the loss, highlighting Rydin's contributions and character, emphasizing his trustworthiness and commitment to both the company and his family. ATEC acknowledges the challenges of moving forward without his leadership during a critical period for the company.
Read more →ATECATEC Reports Third Quarter 2025 Financial Results And Raises Full-Year Guidance • Total revenue grew $46 million or 30% to $197 million • Surgical revenue grew 31% to $177 million • Full-year revenue
Alphatec Holdings, Inc. (ATEC) reported its financial results for the third quarter of 2025, revealing a total revenue increase of 30%, reaching $197 million. Surgical revenue grew by 31%, signaling robust market demand and expanding surgeon adoption. The company raised its full-year guidance for total revenue to $760 million and adjusted EBITDA to approximately $91 million. The results demonstrate strong financial health with positive cash flow and an expanded gross margin.
Read more →ATECATEC Reports Second Quarter 2025 Financial Results And Raises Full-Year Guidance Surgical revenue grew 29% to $168 million Total revenue grew $40 million or 27.5% Full-year revenue and profitability guidance increased
Alphatec Holdings, Inc. (ATEC) announced its financial results for the second quarter of 2025, reporting a total revenue of $186 million, which represents a 27.5% increase from the previous year. Surgical revenue saw a significant rise of 29% to $168 million, driven by continued momentum in new surgeon adoption and innovative products. ATEC also raised its full-year revenue guidance to a projected $742 million, reflecting strong operational execution and a favorable market position.
Read more →ATECATEC Reports First Quarter 2025 Financial Results And Raises Full-Year Guidance Surgical revenue grew 24%; total revenue grew 22% Full-year revenue and profitability guidance increased Successfully refinanced convertible
Alphatec Holdings, Inc. (ATEC) reported robust financial results for the first quarter of 2025, with total revenue reaching $169 million and surgical revenue rising by 24%. The company has raised its full-year guidance, now anticipating total revenue growth of 20% and non-GAAP adjusted EBITDA to improve to approximately $78 million. The successful refinancing of convertible debt to maturity in 2030 further solidifies ATEC's financial standing. Overall, the company demonstrates strong growth potential and positive management outlook for the remainder of the year.
Read more →ATECATEC Prices Upsized $350.0 Million Convertible Senior Notes Offering
Alphatec Holdings, Inc. (ATEC) announced the upsized pricing of its $350 million convertible senior notes offering due in 2030, increasing from the originally planned $300 million. The offering is set to settle on March 7, 2025, and features a low interest rate of 0.75% with the potential for noteholders to convert their notes into common stock. Notably, this offering aims to raise approximately $339 million for various corporate needs and includes capped call transactions to mitigate potential stock dilution. The initiative reflects strong investor interest, evidenced by the premium on the conversion price relative to existing stock prices.
Read more →ATECATEC Announces Proposed Convertible Senior Notes Offering
Alphatec Holdings, Inc. (ATEC) has announced a proposed offering of $300 million in convertible senior notes due 2030 to qualified institutional buyers. Additionally, an option to purchase up to $50 million in additional notes may be granted. The notes will be unsecured and accrue interest payable semi-annually. ATEC anticipates using a portion of the proceeds to fund capped call transactions, repurchase existing convertible notes, and for general corporate purposes. The offering is subject to market conditions and other regulatory requirements.
Read more →ATECATEC Reports Fourth Quarter and Full Year 2024 Financial Results Full year 2024 total revenue grew 27% to $612 million, enabling significant profit margin expansion Full year 2025 total revenue expected to approximate $7
Alphatec Holdings, Inc. (ATEC) reported fourth quarter and full year 2024 financial results, highlighting a 27% increase in total revenue to $612 million. The company entered Japan's spine surgery market, achieving a successful surgery, and saw significant growth in surgical revenue and user adoption. ATEC estimates total revenue for 2025 to reach approximately $732 million, reflecting continued growth and positive free cash flow. The company remains focused on innovating and expanding within the spine care sector.
Read more →ATEC▲ +9.1%on this news
ATEC Announces Select Preliminary Financial Results for 2024 and Provides 2025 Outlook Full-year 2024 total revenue grew 27% to approximately $611 million Expect full-year 2025 total revenue of $732 million and positive
Alphatec Holdings, Inc. (ATEC) announced preliminary financial results for 2024, reflecting a 27% revenue growth to approximately $611 million. The company projects total revenue for 2025 of $732 million, marking an anticipated growth of 20%. Key drivers of growth include strong surgeon adoption and an increase in surgical volume. ATEC also indicates expected positive free cash flow for 2025, enhancing its financial outlook.
Read more →ATECATEC Reports Third Quarter 2024 Financial Results And Raises Full-Year Guidance Surgical revenue grew 30%; total revenue grew 27% Full-year revenue and profitability guidance increased Enhanced balance sheet flexibility
Alphatec Holdings, Inc. (ATEC) reported strong financial results for the third quarter of 2024, with surgical revenue up 30% and total revenue increasing by 27%. The company raised its full-year guidance, expecting total revenue to grow by 25% to $605 million. Additionally, ATEC improved its financial flexibility by expanding an existing term loan by $50 million. Despite these positive results, the company reported a net loss of $40 million and acknowledged uncertainties regarding future growth and product development.
Read more →ATECATEC Reports Second Quarter 2024 Financial Results And Raises Full-Year Guidance Surgical revenue grew 27% and drove total revenue growth of 25% to $146 million Full-year revenue and profitability guidance increased
Alphatec Holdings, Inc. (ATEC) reported significant second-quarter financial results for 2024, with total revenue reaching $146 million, a 25% increase driven by a 27% rise in surgical revenue. The company has raised its full-year guidance to an expected total revenue of $602 million, reflecting stronger anticipated performance. Notably, ATEC launched EOS Insight, aimed at improving spine surgeries, and saw a 20% growth in new surgeon adoption. Additionally, Keith Valentine has joined the Board of Directors, bringing over 30 years of industry experience.
Read more →ATECATEC Reports First Quarter 2024 Financial Results And Raises Full-Year Guidance Total revenue grew 27% to $138 million, with 30% growth in surgical revenue Adjusted EBITDA margin expanded 450 basis points Full-year reven
Alphatec Holdings, Inc. (ATEC) reported its financial results for the first quarter of 2024, revealing a 27% increase in total revenue, amounting to $138 million, alongside a 30% rise in surgical revenue. The adjusted EBITDA margin also improved significantly by 450 basis points. In light of the strong performance, ATEC increased its full-year revenue guidance from $595 million to $601 million, projecting continued growth in surgical and EOS revenues. The company expressed confidence in its ability to capitalize on market opportunities with innovative solutions in spine surgery.
Read more →ATECATEC Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Highlights Full year 2023 total revenue grew 37% to $482 million Full year 2023 adjusted EBITDA margin improved ~890 basis points Full
Alphatec Holdings, Inc. (ATEC) announced its financial results for the fourth quarter and full year ended December 31, 2023, revealing a significant revenue growth of 37% year-over-year, totaling $482 million. The company also reported an improvement in adjusted EBITDA margin, reflecting operational efficiencies. However, ATEC faced a net loss, marking challenges despite favorable revenue trends. Looking ahead, the company expects total revenue to rise to approximately $595 million in 2024, along with an anticipated enhanced EBITDA margin.
Read more →ATEC▲ +9.1%on this news
ATEC Announces Record Preliminary Revenue Results for 2023 and 2024 Revenue Guidance Full-year 2023 total revenue grew approximately 37% to over $480 million Expected full-year 2024 total revenue of $595 million
Alphatec Holdings, Inc. (ATEC) announced record preliminary revenue results for the full year 2023, reporting a growth of approximately 37% to over $480 million. The company also provided guidance for 2024, expecting total revenue to reach $595 million, reflecting a growth of 23% to 24%. Key contributors to this growth include an increase in surgical revenue linked to their lateral franchise innovations. ATEC's focus on spine surgery continues to position it for future growth, with further financial details set to be released in February 2024.
Read more →ATECATEC Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Adjusted EBITDA Guidance Total revenue grew 32% to $118 million Surgical revenue grew 32% to $104 million and EOS revenue grew 30% to $14 millio
Alphatec Holdings, Inc. (ATEC) reported strong financial results for the third quarter of 2023, with total revenues increasing by 32% to $118 million. The surgical revenue also saw a similar growth of 32%, reaching $104 million. The company delivered a positive adjusted EBITDA of over $2 million and raised its full-year adjusted EBITDA guidance to approximately $3 million. ATEC continues to invest in its operational capacity and innovation in spine surgery technology.
Read more →ATECATEC Announces Pricing of Public Offering of Common Stock
Alphatec Holdings, Inc. (ATEC) has announced the pricing of a public offering for 14,300,000 shares of its common stock at $10.50 per share, aiming to raise approximately $150 million. The offering, set to close on October 27, is subject to the satisfaction of customary closing conditions. Notably, ATEC has granted underwriters an option to purchase an additional 2,145,000 shares. This capital influx is intended to support ATEC's initiatives in spine surgery innovations.
Read more →ATECATEC Announces Proposed Public Offering of Common Stock
Alphatec Holdings, Inc. (ATEC) has announced a proposed public offering of $150 million in common stock, with an option for underwriters to purchase an additional $22.5 million. The offering is contingent on market conditions and is being managed by investment firms including Stanley, TD Cowen, Barclays, and Stifel. ATEC emphasizes that the offering is made under the stipulations of a previously filed shelf registration statement and provides detailed instructions for obtaining the prospectus. The company continues to focus on advancing spine surgery technologies through its subsidiaries and innovative solutions.
Read more →ATECATEC Enhances Board with Renowned Spine Prowess Dave Demski appointed to Board of Directors Keith Valentine appointed Special Advisor to Board of Directors
Alphatec Holdings, Inc. (ATEC) has announced the appointment of Dave Demski and Keith Valentine to its Board of Directors as part of a strategic enhancement. Demski, a former CEO of Globus Medical, and Valentine, a former CEO of Orthofix, bring a combined 50 years of experience in spine surgery advancements. This move signals ATEC's commitment to strengthen its leadership and improve its offerings in the spine care market. Additionally, CEO Pat Miles expressed confidence in their capabilities despite prior negative commentary surrounding Valentine.
Read more →ATECATEC Announces Preliminary Third Quarter 2023 Revenue Results and Raises Full-Year Revenue Guidance Total revenue of $117.7 to $118.5 million Total revenue growth of 31% to 32% Full-year 2023 total revenue now expected t
Alphatec Holdings, Inc. (ATEC) reported preliminary financial results for Q3 2023, revealing total revenue expected to be between $117.7 million and $118.5 million, reflecting a growth of 31% to 32% compared to the previous year. The company has raised its full-year 2023 revenue guidance to approximately $472 million from an earlier estimate of $462 million. ATEC attributes this significant growth to the strong adoption of its surgical solutions. Upcoming investor meetings are scheduled to discuss the company's innovations further, with more detailed financial results to be announced on November 6, 2023.
Read more →ATECATEC Reports Second Quarter 2023 Financial Results and Raises Full Year 2023 Revenue and Adjusted EBITDA Guidance Total revenue grew 39% to $117 million Surgical revenue grew 41% to $102 million and EOS revenue grew 24%
Alphatec Holdings, Inc. (ATEC) has reported robust financial results for the second quarter of 2023, with total revenue reaching $117 million, a 39% increase compared to the previous year. Surgical revenue saw an impressive 41% growth, reflecting strong market adoption of their innovations. The company also reported positive adjusted EBITDA exceeding $1 million. In light of this performance, ATEC has raised its full year revenue guidance, anticipating a total of approximately $462 million for 2023.
Read more →ATECATEC Reports First Quarter 2023 Financial Results Total revenue grew 54% to $109 million, including surgical revenue growth of 55% EOS revenue grew to $15 million Adjusted EBITDA margin improved 1,080 basis points year-o
Alphatec Holdings, Inc. (ATEC) reported a strong financial performance for Q1 2023, with total revenue growing 54% to $109 million, driven by surgical revenue growth of 55%. The company aims for a full-year revenue growth of 28% to $450 million. While the adjusted EBITDA margin saw a significant improvement, ATEC continues to face challenges with a GAAP operating loss of $40 million. The company introduced innovative surgical procedures to enhance its market position and expects ongoing advancements in spine surgery technologies.
Read more →ATECAlphatec Holdings Announces $60 Million Underwritten Offering
Alphatec Holdings, Inc. has priced an underwritten offering of 4,285,715 shares of common stock at $14.00 per share, with gross proceeds expected to be approximately $60 million. The offering, which is subject to customary closing conditions, is set to close on or about April 21, 2023. TD Cowen is acting as the sole book-runner for this offering. This capital raise has the potential to bolster the company's innovative solutions aimed at enhancing spine surgery.
Read more →ATECATEC Reports Record Fourth Quarter and Full-Year 2022 Financial Results and Recent Corporate Highlights Full-year revenue grows 44% to $351 million, including EOS revenue of $48 million Fourth quarter revenue grows 43% t
Alphatec Holdings, Inc. (ATEC) reported record financial results for both the fourth quarter and full-year 2022, with a 44% revenue growth to $351 million. The company achieved notable increases in surgical volume and revenue per procedure, alongside a significant rise in trained surgeon users. Despite the positive financial trajectory, ATEC continues to face challenges with operating losses. The outlook for 2023 is optimistic, projecting a total revenue of $438 million, marking a 25% increase from the previous year.
Read more →ATEC▼ -5.1%on this news
ATEC Announces Select Preliminary Financial 2022 Results, 2023 Guidance and Closing of Flexible, Non-Dilutive Debt Facility Full-year 2022 total revenue grew approximately 44% to over $350 million Expected 2023 full-year
Alphatec Holdings, Inc. (ATEC) reported a substantial revenue growth of approximately 44% for the full year 2022, amounting to over $350 million. The company provided guidance for the upcoming year, forecasting a total revenue of $438 million for 2023. Additionally, ATEC announced the closing of a $150 million non-dilutive term loan agreement aimed at bolstering its financial position and supporting further market strategies. The company's projections include plans for achieving break-even adjusted EBITDA in 2023.
Read more →ATECATEC Reports Third Quarter 2022 Financial Results Total revenue grew 43% to $90 million, including surgical revenue growth of 53% EOS revenue of $11 million Adjusted EBITDA improved significantly, both year-over-year and
ATEC Reports Third Quarter 2022 Financial Results Total revenue grew 43% to $90 million, including surgical revenue growth of 53% EOS revenue of $11 million Adjusted EBITDA improved significantly, both year-over-year and sequentially CARLSBAD, Calif., November 3, 2022 Alphate
Read more →ATECATEC Reports Second Quarter 2022 Financial Results and Increases Full-Year Revenue Guidance Total revenue grows 35% to $84 million, including organic revenue growth of 30% EOS imaging generates revenue of $12 million Com
ATEC Reports Second Quarter 2022 Financial Results and Increases Full-Year Revenue Guidance Total revenue grows 35% to $84 million, including organic revenue growth of 30% EOS imaging generates revenue of $12 million Company increases full-year revenue guidance to $325 millio
Read more →ATECATEC to Host Investor Day Today
ATEC to Host Investor Day Today, May 25, 2022 CARLSBAD, Calif., May 25, 2022 - Alphatec Holdings Inc. (Nasdaq: ATEC) announced that it will host an Investor Day at the Company's headquarters in Carlsbad, CA, today. The event, which will highlight ATEC's commitment to revolutioni
Read more →ATECATEC Reports First Quarter 2022 Financial Results and Increases Full-Year Revenue Guidance Revenue growth of 61%, including organic revenue growth of 39% EOS imaging revenue of over $10 million Full-year revenue guidance
ATEC Reports First Quarter 2022 Financial Results and Increases Full-Year Revenue Guidance Revenue growth of 61%, including organic revenue growth of 39% EOS imaging revenue of over $10 million Full-year revenue guidance increased to $316 million, reflecting 30% growth Inves
Read more →ATECATEC Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Highlights Revenue growth of 68% for full year 2021, including organic revenue growth of 50% U.S. organic revenue 3-year CAGR of 36% F
ATEC Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Highlights Revenue growth of 68% for full year 2021, including organic revenue growth of 50% U.S. organic revenue 3-year CAGR of 36% Fourth quarter EOS imaging-related revenue of $12.8 milli
Read more →ATEC▲ +12.8%on this news
ATEC Announces Preliminary 2021 Revenue Results and 2022 Guidance Full-year 2021 U.S. organic revenue growth of 50% to 51% driven primarily by accelerated PTP adoption Fourth quarter 2021 U.S. organic revenue growth of 4
ATEC Announces Preliminary 2021 Revenue Results and 2022 Guidance Full-year 2021 U.S. organic revenue growth of 50% to 51% driven primarily by accelerated PTP adoption Fourth quarter 2021 U.S. organic revenue growth of 41% to 42% Full-year 2022 total revenue expected to grow a
Read more →ATECATEC Reports Third Quarter Financial Results and Recent Corporate Highlights Total revenue growth of 53% including organic revenue growth of 29% Advancing adoption of PTP Technique drove 50% lateral contribution to reven
ATEC Reports Third Quarter Financial Results and Recent Corporate Highlights Total revenue growth of 53% including organic revenue growth of 29% Advancing adoption of PTP Technique drove 50% lateral contribution to revenue growth Revenue related to EOS imaging exceeded $11 mil
Read more →ATEC▼ -8.6%on this news
ATEC Provides Business Update
ATEC Provides Business Update CARLSBAD, Calif., September 28, 2021 - Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, provided a business update today, ahead of investor meetings scheduled for
Read more →ATEC▼ -9.1%on this news
Alphatec Holdings, Inc. Prices Upsized $275.0 Million Convertible Senior Notes Offering CARLSBAD, California-(GLOBAL NEWSWIRE)
Alphatec Holdings, Inc. Prices Upsized $275.0 Million Convertible Senior Notes Offering CARLSBAD, California-(GLOBAL NEWSWIRE)-August 5, 2021-Alphatec Holdings, Inc. (Nasdaq: ATEC) today announced the pricing of its offering of $275,000,000 aggregate principal amount of 0.75% co
Read more →ATEC▲ +6.7%on this newsshared move
Alphatec Holdings, Inc. Announces Proposed Convertible Senior Notes Offering CARLSBAD, California-(GLOBAL NEWSWIRE)
Alphatec Holdings, Inc. Announces Proposed Convertible Senior Notes Offering CARLSBAD, California-(GLOBAL NEWSWIRE)-August 4, 2021-Alphatec Holdings, Inc. (Nasdaq: ATEC) today announced its intention to offer, subject to market and other conditions, $250,000,000 aggregate princi
Read more →ATEC▲ +6.7%on this newsshared move
CARLSBAD, California-(GLOBAL NEWSWIRE)
CARLSBAD, California-(GLOBAL NEWSWIRE)-August 4, 2021-Alphatec Holdings, Inc. (Nasdaq: ATEC) today announced its intention to offer, subject to market and other conditions, $250,000,000 aggregate principal amount of convertible senior notes due 2026 (the "notes") in a private off
Read more →ATECATEC Reports Second Quarter Financial Results and Recent Corporate Highlights Organic revenue growth accelerates to 93% Revenue 2-year CAGR of 46% Full year 2021 total revenue now expected to grow ~64% to ~$238 million
ATEC Reports Second Quarter Financial Results and Recent Corporate Highlights Organic revenue growth accelerates to 93% Revenue 2-year CAGR of 46% Full year 2021 total revenue now expected to grow ~64% to ~$238 million CARLSBAD, Calif., August 3, 2021 - Alphatec Holdings, Inc
Read more →ATECATEC Appoints Beth Altman to Board of Directors
ATEC Appoints Beth Altman to Board of Directors CARLSBAD, Calif., July 26, 2021 - Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that Beth Altman, former Managing Partner at K
Read more →ATEC▲ +11.6%on this news
ATEC Announces Select Preliminary Second Quarter 2021 Financial Results Second quarter 2021 U.S. organic revenue expected to range from $55.4 million to $56.0 million Full year 2021 U.S. organic revenue growth now expect
ATEC Announces Select Preliminary Second Quarter 2021 Financial Results Second quarter 2021 U.S. organic revenue expected to range from $55.4 million to $56.0 million Full year 2021 U.S. organic revenue growth now expected to exceed 50% CARLSBAD, Calif., July 12, 2021 - Alph
Read more →ATECATEC Appoints Marie Meynadier, Ph.D., to Board of Directors
ATEC Appoints Marie Meynadier, Ph.D., to Board of Directors CARLSBAD, Calif., June 21, 2021 - Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that Marie Meynadier, Ph.D., found
Read more →ATECSTRONG SUCCESS OF THE TENDER OFFER INITIATED BY ALPHATEC HOLDINGS FOR COMMON SHARES AND OCEANES OF EOS IMAGING ATEC secures ~89% of EOS common shares and voting rights as of
STRONG SUCCESS OF THE TENDER OFFER INITIATED BY ALPHATEC HOLDINGS FOR COMMON SHARES AND OCEANES OF EOS IMAGING ATEC secures ~89% of EOS common shares and voting rights as of May 13, 2021 Paris, May 12, 2021- Alphatec Holdings, Inc. (Nasdaq: ATEC) and EOS IMAGING, S.A. are plea
Read more →ATECATEC Reports First Quarter Financial Results and Recent Corporate Highlights U.S. Revenue Growth Accelerates to 50% Revenue Growth Averages ~33% Over Past Eight Quarters
ATEC Reports First Quarter Financial Results and Recent Corporate Highlights U.S. Revenue Growth Accelerates to 50% Revenue Growth Averages ~33% Over Past Eight Quarters CARLSBAD, Calif., May 6, 2021 - Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions
Read more →ATECATEC Announces Preliminary First Quarter 2021 Revenue Results and Provides Corporate Updates First quarter 2021 U.S. revenue grows approximately 50% compared to last year Full year 2021 U.S. revenue growth now expected t
ATEC Announces Preliminary First Quarter 2021 Revenue Results and Provides Corporate Updates First quarter 2021 U.S. revenue grows approximately 50% compared to last year Full year 2021 U.S. revenue growth now expected to exceed 30% Tender offer for EOS imaging cleared by Fre
Read more →ATECATEC Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Corporate Highlights U.S. Revenue Grows 38% in Fourth Quarter and 30% for Full Year Revenue Growth Averages ~30% Over Past Eight Quarters
ATEC Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Corporate Highlights U.S. Revenue Grows 38% in Fourth Quarter and 30% for Full Year Revenue Growth Averages ~30% Over Past Eight Quarters CARLSBAD, Calif., March 04, 2021 (GLOBE NEWSWIRE) -- Alphatec H
Read more →ATECany forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by law. Investor/Media Contact: Tina Jacobsen Investor Relations (760) 494-6790 investorrelations@atecs
ATEC Announces Preliminary 2020 Revenue Results CARLSBAD, Calif., January 12, 2021 - Alphatec Holdings, Inc. ("ATEC" or the "Company") (Nasdaq: ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today preliminary revenue results
Read more →ATECATEC Continues to Advance Clinical Prowess with Renewed Agreement to Acquire EOS Imaging Improves clinical performance in spine by adding unprecedented information to the AlphaInformatiX Platform Accelerates revenue grow
ATEC Continues to Advance Clinical Prowess with Renewed Agreement to Acquire EOS Imaging CARLSBAD, Calif., December 16, 2020 Alphatec Holdings, Inc. ( ATEC or the Company ) (Nasdaq: ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, ann
Read more →ATECATEC Reports Third Quarter 2020 Financial Results and Recent Corporate Highlights U.S. Revenue Grows 43% Eighth Consecutive Quarter of Double-Digit Revenue Growth
ATEC Reports Third Quarter 2020 Financial Results and Recent Corporate Highlights U.S. Revenue Grows 43% Eighth Consecutive Quarter of Double-Digit Revenue Growth CARLSBAD, Calif., November 5, 2020 - Alphatec Holdings, Inc. ("ATEC" or the "Company") (Nasdaq: ATEC), a provider
Read more →ATECATEC ANNOUNCES PRELIMINARY THIRD QUARTER 2020 FINANCIAL RESULTS Third quarter U.S. revenue expected to grow over 40% Eighth consecutive quarter of double-digit revenue growth Revenue per case expands on strong pull- thro
ATEC ANNOUNCES PRELIMINARY THIRD QUARTER 2020 FINANCIAL RESULTS CARLSBAD, Calif., October 7, 2020 Alphatec Holdings, Inc. ( ATEC or the Company ) (Nasdaq: ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today preliminary, u
Read more →ATECAlphatec to Participate in Upcoming Investor Conferences
CARLSBAD, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC) (“Alphatec” or the “Company”), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced today that Pat Miles, Chief Executive
Read more →ATECATEC Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights U.S. Revenue Grows 11% Seventh Consecutive Quarter of Year-Over-Year Double-Digit Revenue Increase
ATEC Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights CARLSBAD, Calif., August 6, 2020 - Alphatec Holdings, Inc. ("ATEC" or the "Company") (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to
Read more →ATECAlphatec to Participate in 40th Annual Canaccord Growth Conference
CARLSBAD, Calif., July 31, 2020 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC) (“Alphatec” or the “Company”), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced today that Pat Miles, Chief Executive O
Read more →ATECAlphatec to Report Second Quarter 2020 Financial Results on August 6, 2020
CARLSBAD, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC) (“ATEC” or the “Company”), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will release second quarter f
Read more →ATECATEC Reports First Quarter 2020 Financial Results and Recent Corporate Highlights New Product Adoption Drives U.S. Revenue Growth of 27% Additional $35 Million Capital Commitment Provides Runway for Continued Execution
ATEC Reports First Quarter 2020 Financial Results and Recent Corporate Highlights New Product Adoption Drives U.S. Revenue Growth of 27% Additional $35 Million Capital Commitment Provides Runway for Continued Execution CARLSBAD, Calif., May 11, 2020 - Alphatec Holdings, Inc. (
Read more →ATECAlphatec to Report First Quarter 2020 Financial Results on May 11, 2020
CARLSBAD, Calif., April 28, 2020 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC) (“ATEC” or the “Company”), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will release first quarter f
Read more →ATECAbout EOS imaging Based in Paris, EOS imaging is a global medical device company that develops and markets advanced imaging and image-based solutions for musculoskeletal pathologies and orthopedic surgical care. EOS imag
ATEC Terminates Agreement to Acquire EOS Imaging Ongoing Impacts of COVID-19 Pandemic Constitute "Material Adverse Effect" Company Intends to Explore Other Strategic Collaborations with EOS Terminates Debt Commitment of up to $160 Million to Finance Acquisition and Retire Exis
Read more →ATECATEC Reports Fourth Quarter and Full Year 2019 Financial Results U.S. Revenue Grew Nearly 30% Year-Over-Year for the Full Year And 35% Year-Over-Year in the Fourth Quarter
ATEC Reports Fourth Quarter and Full Year 2019 Financial Results U.S. Revenue Grew Nearly 30% Year-Over-Year for the Full Year And 35% Year-Over-Year in the Fourth Quarter CARLSBAD, Calif., March 5, 2020 - Alphatec Holdings, Inc. ("ATEC" or the "Company") (Nasdaq: ATEC), today
Read more →ATECATEC Announces Agreement to Acquire EOS imaging Accelerates revenue by creating significant pull-through and cross-selling opportunities via an expanded sales network and combined customer base, including 350+ installed
ATEC Announces Agreement to Acquire EOS imaging CARLSBAD, Calif., February 28, 2020 Alphatec Holdings, Inc. ( ATEC or the Company ) (Nasdaq: ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today that it has entered into an a
Read more →ATECAlphatec to Report Fourth Quarter and Fiscal Year 2019 Financial Results on March 5th 2020, and Participate in Upcoming Investor Conference
CARLSBAD, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC) (“Alphatec” or the “Company”), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will release fourth quart
Read more →ATECATEC Announces Preliminary 2019 Revenue Results and 2020 Revenue Outlook • Full-year 2019 U.S. revenue growth approximately 30% • Fourth quarter year-over-year U.S. revenue growth approximately 35% •
ATEC Announces Preliminary 2019 Revenue Results and 2020 Revenue Outlook CARLSBAD, Calif., January 13, 2020 - Alphatec Holdings, Inc. ("ATEC" or the "Company") (Nasdaq: ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today pr
Read more →ATECATEC Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights Third Quarter U.S. Revenue Growth of 34% Year-Over-Year Drives Increase in Full Year 2019 Guidance
ATEC Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights Third Quarter U.S. Revenue Growth of 34% Year-Over-Year Drives Increase in Full Year 2019 Guidance CARLSBAD, Calif., October 30, 2019 - Alphatec Holdings, Inc. ("ATEC" or the "Company") (Nasdaq:
Read more →ATECAlphatec Enhances its Lateral Portfolio With the Commercial Launch of Approach-Specific Innovation
CARLSBAD, Calif., Oct. 22, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today the commercial release of its porous titanium line of IdentiT
Read more →ATECAlphatec to Report Third Quarter 2019 Financial Results on October 30, 2019
CARLSBAD, Calif., Oct. 10, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC) (“ATEC” or the “Company”), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announced that the Company plans to release thi
Read more →ATECAlphatec Announces Commercial Launch of IdentiTi™ TLIF Posterior Oblique Porous Titanium Interbody Implant System
CARLSBAD, Calif., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today the commercial release of its IdentiTi TLIF Posterior Obliqu
Read more →ATECAlphatec Announces Favorable Judgment in NuVasive v. Miles Lawsuit
CARLSBAD, Calif., Aug. 27, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or “the Company”) (Nasdaq: ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today that the Delaware Chancery Court entered summary judgment in
Read more →ATECAlphatec to Participate in the H.C. Wainwright 21st Annual Global Investment Conference and the Lake Street Capital Markets 3rd Annual Best Ideas Growth Conference
CARLSBAD, Calif., Aug. 26, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announced that the Company will participate in
Read more →ATECAlphatec Accelerates Organic Innovation Machine™ With Key Senior Leadership Appointment and Continued Sales Team Enhancements
• Eric Dasso to Lead Revolutionary Alpha InformatiX™ Platform • Wyatt Stanfield to Drive Western US Sales Expansion CARLSBAD, Calif., Aug. 15, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a medical device company dedicated to revo
Read more →ATECAlphatec Advances InVictus™ MIS Spinal Fixation System With Commercial Launch of SingleStep™
CARLSBAD, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today the commercial release of InVictus Minimally Invasive, or MIS
Read more →ATECAlphatec to Present at the Canaccord Genuity 39th Annual Growth Conference
CARLSBAD, Calif., Aug. 02, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announced that it will attend the 39th Annual G
Read more →ATECAlphatec Holdings, Inc. Announces Closing of Public Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Stock
CARLSBAD, Calif., Aug. 02, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC”) (NASDAQ: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announced the closing of its previously announced underwritten p
Read more →ATECAlphatec Holdings, Inc. Announces Pricing of Public Offering of Common Stock
Alphatec Holdings, Inc. Announces Pricing of Public Offering of Common Stock CARLSBAD, California, July 31, 2019 Alphatec Holdings, Inc. ( ATEC ) (NASDAQ: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today a
Read more →ATECAlphatec Holdings, Inc. Announces Proposed Public Offering of Common Stock
Alphatec Holdings, Inc. Announces Proposed Public Offering of Common Stock CARLSBAD, California, July 30, 2019 Alphatec Holdings, Inc. ( ATEC ) (NASDAQ: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today ann
Read more →ATECAlphatec Reports Second Quarter 2019 Financial Results and Corporate Highlights
Full Year 2019 Revenue Guidance Increased Following 28% Q2 U.S. Revenue Growth CARLSBAD, Calif., July 24, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the
Read more →ATECAlphatec Reports Second Quarter 2019 Financial Results and Corporate Highlights Full Year 2019 Revenue Guidance Increased Following 28% Q2 U.S. Revenue Growth
Alphatec Reports Second Quarter 2019 Financial Results and Corporate Highlights Full Year 2019 Revenue Guidance Increased Following 28% Q2 U.S. Revenue Growth CARLSBAD, Calif., July 24, 2019 - Alphatec Holdings, Inc. ("ATEC" or the "Company") (Nasdaq: ATEC), a provider of inno
Read more →ATECAlphatec Announces Commercial Launch of the InVictus™ MIS and Open Spinal Fixation Systems
CARLSBAD, Calif., July 23, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today the commercial release of InVictus™, a comprehensive spinal f
Read more →ATECAlphatec Announces Commercial Launch of ALIF IdentiTi™ Porous Titanium Interbody System Implant
CARLSBAD, Calif., July 18, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today the commercial release of its IdentiTi Large Window Porous Ti
Read more →ATECAlphatec to Report Second Quarter 2019 Financial Results on July 24, 2019
CARLSBAD, Calif., July 11, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC) (“ATEC” or the “Company”), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announced that the Company plans to release sec
Read more →ATECAlphatec Announces Organizational and Corporate Updates
Appointment of Karen McGinnis to Board of Directors Inclusion in Russell 2000® Index Drawdown on Squadron Credit Facility CARLSBAD, Calif., June 27, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surger
Read more →ATECdescribed in the forward-looking statements. The Company cautions investors that there can be no assurance that actual results or business conditions will not differ materially from those projected or suggested in such f
Alphatec Announces Organizational and Corporate Updates CARLSBAD, Calif., June 27, 2019 - Alphatec Holdings, Inc. ("ATEC" or the "Company") (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announce
Read more →ATECAlphatec Announces Updated Presentation Date and Time at the Raymond James Life Sciences and MedTech Conference
CARLSBAD, Calif., June 12, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announced that Jeff Black, Executive Vice Presi
Read more →ATECAlphatec Announces Commercial Launch of TLIF IdentiTi™ Posterior Curved Porous Titanium Interbody Implant System
CARLSBAD, Calif., May 30, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today the commercial release of its IdentiTi-PC Porous Titanium Inte
Read more →ATECAlphatec to Participate in the Jefferies 2019 Global Healthcare Conference and the Raymond James Life Sciences and MedTech Conference
CARLSBAD, Calif., May 28, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announced that the Company will participate in t
Read more →ATECAlphatec to Present at the 20th Annual B. Riley FBR Investor Conference
CARLSBAD, Calif., May 15, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announced that it will attend the 20th Annual B.
Read more →ATECAlphatec Reports First Quarter 2019 Financial Results and Corporate Highlights
CARLSBAD, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ende
Read more →ATECAlphatec Reports First Quarter 2019 Financial Results and Corporate Highlights Strong Early Traction from New Products Drives U.S. Revenue Growth of 20%
Alphatec Reports First Quarter 2019 Financial Results and Corporate Highlights Strong Early Traction from New Products Drives U.S. Revenue Growth of 20% CARLSBAD, Calif., May 9, 2019 - Alphatec Holdings, Inc. ("ATEC" or the "Company") (Nasdaq: ATEC), a provider of innovative s
Read more →ATECAlphatec Announces Commercial Launch of PLIF IdentiTi™ Posterior Straight Porous Titanium Interbody System Implant and AlphaGRAFT DBM Fiber
CARLSBAD, Calif., May 06, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today the commercial releases of its PLIF IdentiTi-PS Porous Titaniu
Read more →ATECAlphatec to Report First Quarter 2019 Financial Results on May 9, 2019
CARLSBAD, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC) (“Alphatec” or the “Company”), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announced that the Company plans to releas
Read more →ATECAlphatec Announces Sales Leadership Appointment And Successful Closing of Expanded Credit Facility With Squadron Capital
CARLSBAD, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announced the promotion of David Sponsel into
Read more →ATECAlphatec Announces Commercial Launch of its First IdentiTi™ Porous Titanium Interbody System
CARLSBAD, Calif., March 28, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a medical device company dedicated to revolutionizing the approach to spine surgery, announced today the commercial release of its new IdentiTi-C Porous Titanium
Read more →ATECAlphatec Announces Participation At Canaccord and Cowen Investor Conferences in March
CARLSBAD, Calif., March 08, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), today announced it will present at two healthcare investor conferences as follows: ATEC will present at the Cowen 39th Annual Healthcare conference, located at
Read more →ATECAlphatec Spine Reports Fourth Quarter and Full Year 2018 Financial Results Secures Additional $30M Financing Commitment from Squadron Capital
Alphatec Spine Reports Fourth Quarter and Full Year 2018 Financial Results Secures Additional $30M Financing Commitment from Squadron Capital CARLSBAD, Calif., March 7, 2019 - Alphatec Holdings, Inc. ("ATEC" or the "Company") (Nasdaq: ATEC), today announced financial results an
Read more →ATECAlphatec Spine Reports Fourth Quarter and Full Year 2018 Financial Results
CARLSBAD, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), today announced financial results and operating highlights for the fourth quarter and full year ended December 31, 2018. The Company also announced that it has
Read more →ATECAlphatec Announces FDA Clearance of its Automated SafeOp Neuromonitoring System to Address Significant Unmet Needs in Spine Surgery
CARLSBAD, Calif., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC) announced today that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its automated SafeOp neuromonitoring system for use in rea
Read more →ATECAlphatec to Report Fourth Quarter and Fiscal Year 2018 Financial Results on March 7, 2019
CARLSBAD, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC) (“Alphatec” or the “Company”) announced today that the Company plans to release its fourth quarter and fiscal year 2018 financial results on Thursday, March 7, 2019, after the market closes
Read more →ATECAlphatec Announces Stay of Court Proceedings in NuVasive Patent Lawsuit
CARLSBAD, Calif., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or “the Company”) (Nasdaq: ATEC) today announced several favorable developments in its ongoing patent litigation with NuVasive, Inc. (Nasdaq: NUVA). On February 6, 2019, the United States Distric
Read more →ATECAlphatec Announces 2018 Preliminary Revenue Results, 2019 Revenue Outlook, and Senior Leadership Changes CARLSBAD, Calif., (
Alphatec Announces 2018 Preliminary Revenue Results, 2019 Revenue Outlook, and Senior Leadership Changes CARLSBAD, Calif., (January 7, 2019) - Alphatec Holdings, Inc. ("ATEC" or "the Company") (Nasdaq: ATEC) today announced preliminary revenue results for the fourth quarter and
Read more →ATECAlphatec Reports Third Quarter 2018 Financial and Corporate Highlights
CARLSBAD, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC,” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the relentless pursuit of superior outcomes, today reported fina
Read more →ATECAlphatec Reports Third Quarter 2018 Financial Results and Corporate Highlights
Alphatec Reports Third Quarter 2018 Financial Results and Corporate Highlights CARLSBAD, Calif., November 8, 2018 - Alphatec Holdings, Inc. ("ATEC," or the "Company") (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through
Read more →ATECAlphatec Announces Participation at Stifel 2018 Healthcare Conference
CARLSBAD, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the relentless pursuit of superior outcomes, today announced it w
Read more →ATECAlphatec to Report Third Quarter 2018 Financial Results on November 8, 2018
CARLSBAD, Calif., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the relentless pursuit of superior outcomes, announced today
Read more →ATECAlphatec Accelerates Organic Innovation Machine With Addition of Key Senior Leadership and Expansion of Market Development Team
CARLSBAD, Calif., Sept. 27, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the relentless pursuit of superior outcomes, today announced the
Read more →ATECAlphatec Advances Clinical Distinction With OsseoScrew Clearance
CARLSBAD, Calif., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the relentless pursuit of superior outcomes, today announced th
Read more →ATECAlphatec to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
CARLSBAD, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the relentless pursuit of superior outcomes, today announced
Read more →ATECAlphatec Reports Second Quarter 2018 Financial Results
Alphatec Reports Second Quarter 2018 Financial Results CARLSBAD, Calif., August 2, 2018 - Alphatec Holdings, Inc. ("ATEC" or the "Company") (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the relentless pursuit of
Read more →ATECAlphatec to Report Second Quarter 2018 Financial Results on August 2, 2018
CARLSBAD, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (Nasdaq:ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the relentless pursuit of superior outcomes, announced today t
Read more →ATECAlphatec Reports First Quarter 2018 Financial Results And Recent Corporate Highlights
Alphatec Reports First Quarter 2018 Financial Results And Recent Corporate Highlights CARLSBAD, Calif., May 10, 2018 - Alphatec Holdings, Inc. ("Alphatec," "ATEC," or the "Company") (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve patie
Read more →ATECAlphatec Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
CARLSBAD, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“Alphatec,” “ATEC,” or the “Company”) (Nasdaq:ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the relentless pursuit of superior outcomes, today rep
Read more →ATECAlphatec to Report First Quarter 2018 Financial Results on May 10, 2018
CARLSBAD, Calif., April 26, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (Nasdaq:ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the relentless pursuit of superior outcomes, announced today
Read more →ATECSafeOp Surgical, Inc. Financial Statements With Independent Auditor s Report Year Ended
SafeOp Surgical, Inc. Financial Statements With Independent Auditor s Report Year Ended December 31, 2017 SafeOp Surgical, Inc. Page Independent Auditor s Report 1 Financial Statements: Balance Sheet 2 Statement of Operations 3 Statement of Convertible Preferr
Read more →ATECAlphatec Spine Announces Participation at the Oppenheimer & Co. Inc. 28th Annual Healthcare Conference
CARLSBAD, Calif., March 19, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (Nasdaq:ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the relentless pursuit of superior outcomes, today announced
Read more →ATECAlphatec Spine Disrupts Market with Acquisition of SafeOp Surgical, ~$50M Equity Financing, and Strategic Leadership Appointments
Acquisition provides Alphatec most advanced automated neuromonitoring technology Private placement funded by senior leadership, new and existing investors Luiz Pimenta, MD, PhD, to assume role of Chief Medical Officer CARLSBAD, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Alphat
Read more →ATECAlphatec Spine Reports Fourth Quarter and Full Year 2017 Financial Results
Alphatec Spine Reports Fourth Quarter and Full Year 2017 Financial Results CARLSBAD, Calif., March 8, 2018 Alphatec Holdings, Inc. ( Alphatec or the Company ) (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the re
Read more →ATECAlphatec Holdings to Report Fourth Quarter and Fiscal Year 2017 Financial Results on March 8, 2018
CARLSBAD, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC) (the “Company”), the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today that the Company plans to release its fourth quarter and fiscal year 2
Read more →ATECAlphatec Announces Preliminary Fourth Quarter and Full Year 2017 Revenue and Corporate Updates
Alphatec Announces Preliminary Fourth Quarter and Full Year 2017 Revenue and Corporate Updates CARLSBAD, Calif., January 8, 2018 - Alphatec Holdings, Inc. ("Alphatec" or the "Company") (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve pa
Read more →ATECAlphatec Holdings, Inc. Reports Third Quarter 2017 Financial Results Significant progress with transition to dedicated sales organization Continued improvement in operating expense and cash burn man
Alphatec Holdings, Inc. Reports Third Quarter 2017 Financial Results CARLSBAD, Calif., November 9, 2017 -- Alphatec Holdings, Inc. ("Alphatec" or the "Company") (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the r
Read more →ATECAlphatec Holdings, Inc. Reports Third Quarter 2017 Financial Results
Significant progress with transition to dedicated sales organization Continued improvement in operating expense and cash burn management CARLSBAD, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (Nasdaq:ATEC), a provider of innova
Read more →ATECAlphatec Announces Preliminary Third Quarter 2017 Financial Results And Corporate Updates
Alphatec Announces Preliminary Third Quarter 2017 Financial Results And Corporate Updates October 24, 2017 Alphatec Holdings, Inc. ( Alphatec or the Company ) (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the re
Read more →ATECAlphatec Denounces “Baseless” NuVasive Complaint
CARLSBAD, Calif., Oct. 11, 2017 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the relentless pursuit of superior outcomes, released a statement in response to a recent co
Read more →ATECAlphatec Accelerates Business Transformation with Additional Spine-Experienced Leadership Appointments
Patrick Miles to lead company as Executive Chairman Quentin Blackford appointed to Board of Directors Miles and Blackford to make equity investments totaling more than $3.5 million CARLSBAD, Calif., Oct. 02, 2017 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a pro
Read more →ATECAlphatec Accelerates Business Transformation with Additional Spine-Experienced Leadership Appointments Patrick Miles to lead company as Executive Chairman Quentin Blackford appointed to Board of Dir
Alphatec Accelerates Business Transformation with Additional Spine-Experienced Leadership Appointments October 2, 2017 Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the relentless pursuit
Read more →ATECAlphatec Holdings, Inc. Announces Participation at the 19th Annual Rodman & Renshaw Global Investment Conference
CARLSBAD, Calif., Aug. 30, 2017 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (Nasdaq:ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the relentless pursuit of superior outcomes, today announced i
Read more →ATECAlphatec Holdings, Inc. Reports Second Quarter 2017 Financial Results Substantial Improvement in Operating Loss and Non-GAAP Adjusted EBITDA Significant progress with transition to dedicated sales o
Alphatec Holdings, Inc. Reports Second Quarter 2017 Financial Results Substantial Improvement in Operating Loss and Non-GAAP Adjusted EBITDA Significant progress with transition to dedicated sales organization CARLSBAD, Calif., August 10, 2017 Alphatec Holdings, Inc. ( Alphate
Read more →ATECAlphatec Holdings, Inc. Reports Second Quarter 2017 Financial Results
Substantial Improvement in Operating Loss and Non-GAAP Adjusted EBITDA Significant progress with transition to dedicated sales organization CARLSBAD, Calif., Aug. 10, 2017 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (Nasdaq:ATEC), a provider of inn
Read more →ATECAlphatec Holdings to Report Second Quarter 2017 Financial Results on August 10, 2017
CARLSBAD, Calif., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC) (the “Company”), the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today that the Company plans to release its second quarter 2017 financial res
Read more →ATECAlphatec Holdings Reports First Quarter 2017 Financial Results
Alphatec Holdings Reports First Quarter 2017 Financial Results CARLSBAD, Calif., May 11, 2017 Alphatec Holdings, Inc. (Nasdaq: ATEC), the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today recent corporate highlights and financial
Read more →ATECAlphatec Holdings to Report First Quarter 2017 Financial Results on May 11, 2017
CARLSBAD, Calif., May 08, 2017 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC) (the “Company”), the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today that the Company plans to release its first quarter 2017 financial resul
Read more →ATECAlphatec Spine Launches Battalion™ Lateral System with Squadron™ Retractor to support Minimally Invasive Lateral Access Procedures
Opens up new $500M market opportunity in one of the fastest growing segments in spine Squadron™ Lateral Retractor designed to improve patient outcomes All surgeon customers participating in limited market release have booked subsequent cases CARLSBAD, Calif., April 07, 2017 (G
Read more →ATECAlphatec Spine Adds Experienced Spine Executives to Sales Leadership Team
James (Jim) Duffy and Greg Rhinehart Named Area Vice Presidents of Sales New leaders add significant spine-industry experience in building and leading dedicated sales channels CARLSBAD, Calif., April 05, 2017 (GLOBE NEWSWIRE) -- Alphatec Spine, Inc., a wholly owned subsidiary o
Read more →ATECAlphatec Completes its Senior Leadership Team with Appointment of Brian Snider, Executive Vice President, Strategic Marketing and Product Development
Chris Ryan Named Area Vice President of Sales, U.S. Central region New leaders add significant spine-industry experience to build brand awareness and drive market adoption of Alphatec products CARLSBAD, Calif., March 24, 2017 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:
Read more →ATECAlphatec Holdings Announces $18.9 Million Private Placement Proceeds to support corporate growth strategy
Alphatec Holdings Announces $18.9 Million Private Placement Proceeds to support corporate growth strategy CARLSBAD, Calif., March 23, 2017 Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, announced tod
Read more →ATECAlphatec Holdings Announces $18.9 Million Private Placement
CARLSBAD, Calif., March 23, 2017 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today that it has entered into a definitive securities purchase agreement to raise approxima
Read more →ATECAlphatec Holdings Announces Fourth Quarter and Full Year 2016 Financial Results
CARLSBAD, Calif., March 15, 2017 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today financial results for the fourth quarter and full year ended December 31, 2016. Fourt
Read more →ATECAlphatec Spine Appoints Jeffrey G. Black as Chief Financial Officer
CARLSBAD, Calif., March 06, 2017 (GLOBE NEWSWIRE) -- Alphatec Spine, Inc. (Nasdaq:ATEC), a provider of spinal fusion technologies, announced today that it continues its investment in new executive talent with the hiring of Jeffrey G. Black as Executive Vice President and Chief Fi
Read more →ATECAlphatec Spine Appoints Jeffrey G. Black as Chief Financial Officer Financial executive with extensive public-company experience to help strengthen the Company s foundation and position for growth C
Alphatec Spine Appoints Jeffrey G. Black as Chief Financial Officer Financial executive with extensive public-company experience to help strengthen the Company s foundation and position for growth CARLSBAD, CA, March 6, 2017 Alphatec Spine, Inc. (Nasdaq: ATEC), a provider of s
Read more →ATECAlphatec’s Arsenal™ Deformity Adolescent Scoliosis (AIS) System Launched in Limited Markets in the U.S.
CARLSBAD, Calif., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Alphatec Spine, Inc., (Nasdaq:ATEC), a global provider of spinal fusion technologies, announced today that the Company has launched its new Arsenal Deformity Adolescent Idiopathic Scoliosis (AIS) System and has successfully comp
Read more →ATECAlphatec Spine Announces Appointment of David H. Mowry to its Board of Directors
CARLSBAD, Calif., Feb. 14, 2017 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today that its board of directors has appointed David H. Mowry as a member of the board of di
Read more →ATECAlphatec Holdings Announces Board and Executive Leadership Changes Experienced Orthopedics and Spine Executive, Terry M. Rich, joins as CEO and Board Member Mortimer Berkowitz III appointed Chairman
Alphatec Holdings Announces Board and Executive Leadership Changes Experienced Orthopedics and Spine Executive, Terry M. Rich, joins as CEO and Board Member Mortimer Berkowitz III appointed Chairman of the Board New Commercial Leadership Team Hired CARLSBAD, Calif., December
Read more →ATECAlphatec Holdings Announces Board and Executive Leadership Changes
Experienced Orthopedics and Spine Executive, Terry M. Rich, joins as CEO and Board Member Mortimer Berkowitz III appointed Chairman of the Board New Commercial Leadership Team Hired CARLSBAD, Calif., Dec. 12, 2016 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the
Read more →ATECAlphatec Holdings Announces Third Quarter 2016 Revenue and Financial Results
CARLSBAD, Calif., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today financial results for the third quarter ended September 30, 2016. Today the Company als
Read more →ATECAlphatec Spine to Showcase New Minimally Invasive (MIS) and Complex Spine Products at the Upcoming 31st Annual North American Spine Society (NASS) Meeting in Boston
CARLSBAD, Calif., Oct. 18, 2016 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today that it will introduce several new products, as well as its current comprehensive portf
Read more →ATECAlphatec Holdings Announces Company Updates
CARLSBAD, Calif., Oct. 05, 2016 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, today announced changes to the Company’s executive leadership team, a reduction in the Company’s workfo
Read more →ATECAlphatec Holdings Announces Company Updates Company Names Chairman Leslie H. Cross as Interim CEO Regains Compliance with Nasdaq Listing Requirements
Alphatec Holdings Announces Company Updates Company Names Chairman Leslie H. Cross as Interim CEO Regains Compliance with Nasdaq Listing Requirements CARLSBAD, Calif., September 15, 2016 Alphatec Holdings, Inc. (Nasdaq: ATEC), the parent company of Alphatec Spine, Inc., a prov
Read more →ATECAlphatec Holdings Completes Sale of International Business to Globus Medical Substantially reduced debt and improved balance sheet strengthens Alphatec's financial position and enables future growth strategies
Alphatec Holdings Completes Sale of International Business to Globus Medical Substantially reduced debt and improved balance sheet strengthens Alphatec's financial position and enables future growth strategies CARLSBAD, Calif., September 1, 2016 - Alphatec Holdings, Inc. (Nasda
Read more →ATECAlphatec Holdings Announces One-for-Twelve Reverse Stock Split
CARLSBAD, Calif., Aug. 24, 2016 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, today announced the effectiveness of a one-for-twelve reverse stock split of its common stock. T
Read more →ATECAlphatec Holdings Announces Sale of International Business to Globus Medical
CARLSBAD, Calif., July 26, 2016 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that it has entered into a definitive agreement with Globus Medical (NYSE:GMED),
Read more →ATECALPHATEC HOLDINGS, INC. RECONCILIATION OF GEOGRAPHIC SEGMENT REVENUES AND GROSS PROFIT (in thousands, except percentages - unaudited) Three Months Ended % Change December 31, % Change % Change Foreign 2015 2014 As Report
Alphatec Holdings Announces Fourth Quarter and Full Year 2015 Revenue and Financial Results Company Announces Extension of Credit Agreement Maturity CARLSBAD, Calif., Mar. 15, 2016 -- Alphatec Holdings, Inc. (Nasdaq: ATEC), the parent company of Alphatec Spine, Inc., a global p
Read more →ATECAlphatec Holdings Announces Fourth Quarter and Full Year 2015 Revenue and Financial Results
CARLSBAD, Calif., March 15, 2016 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today financial results for the fourth quarter and full year ended December 31, 2015.
Read more →ATECAlphatec Spine to Present at 27th Annual Piper Jaffray Healthcare Conference
CARLSBAD, Calif., Nov. 17, 2015 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that the Company’s executives, Jim Corbett, President and Chief Executive Office
Read more →ATECAlphatec Holdings Announces Third Quarter 2015 Revenue and Financial Results CARLSBAD, CA
Alphatec Holdings Announces Third Quarter 2015 Revenue and Financial Results CARLSBAD, CA, November 3, 2015 Alphatec Holdings, Inc. (Nasdaq: ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today financial results for
Read more →ATECAlphatec Holdings Announces Third Quarter 2015 Revenue and Financial Results
CARLSBAD, Calif., Nov. 03, 2015 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today financial results for the third quarter ended September 30, 2015. Third quarter
Read more →ATECAlphatec Spine Announces Retirement of James R. Glynn From Its Board of Directors; Donald A. Williams Appointed Audit Committee Chairman
CARLSBAD, Calif., Oct. 30, 2015 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that James R. Glynn is retiring as a member of the board of directors and Audit
Read more →ATECAlphatec Spine Introduces New Titanium-Coated PEEK Interbody Fusion System
First Battalion™ Universal Spacer System Surgical Case Completed in the U.S. Featured at NASS Booth #1147 CARLSBAD, Calif., Oct. 12, 2015 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion te
Read more →ATECAlphatec Spine Launches Alphatec Neocore(TM) Osteoconductive Matrix in the U.S.
First Patient Surgical Implantation Successfully Completed Featured at NASS Booth #1147 CARLSBAD, Calif., Oct. 01, 2015 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announ
Read more →ATECAlphatec’s Less-Invasive Arsenal(TM) Cortical Bone Fixation System Successfully Used in Over 50 Patients
Arsenal CBx™ to Enter Full Commercial Launch by Year-end Featured at NASS Booth #1147 CARLSBAD, Calif., Sept. 24, 2015 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announc
Read more →ATECAlphatec’s Arsenal(TM) Spinal Fixation System Further Expanded to Address Broader Market
Arsenal™ Osteotomy Instrument Set Launched to Support Complex Spinal Cases Featured at NASS Booth #1147 CARLSBAD, Calif., Sept. 17, 2015 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion tec
Read more →ATECAlphatec Holdings Announces Second Quarter 2015 Revenue and Financial Results CARLSBAD, CA
Alphatec Holdings Announces Second Quarter 2015 Revenue and Financial Results CARLSBAD, CA, August 4, 2015 Alphatec Holdings, Inc. (Nasdaq: ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today financial results for
Read more →ATECAlphatec Holdings Announces Second Quarter 2015 Revenue and Financial Results
CARLSBAD, Calif., Aug. 04, 2015 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today financial results for the second quarter ended June 30, 2015. Second quarter co
Read more →ATECAlphatec Spine to Release Second Quarter 2015 Financial Results
CARLSBAD, Calif., July 21, 2015 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global medical device company that provides spinal fusion technology solutions for patients with spinal disorders, will release its second quar
Read more →ATECAlphatec Spine to Present at the Jefferies 2015 Global Healthcare Conference
CARLSBAD, Calif., May 20, 2015 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that the Company's President and Chief Executive Officer, Jim Corbett, will parti
Read more →ATECAlphatec Spine to Present at UBS 2015 Global Healthcare Conference
CARLSBAD, Calif., May 6, 2015 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that the Company's President and Chief Executive Officer, Jim Corbett, will partic
Read more →ATECAlphatec Spine Announces Appointment of Donald A. Williams to its Board of Directors
CARLSBAD, Calif., May 1, 2015 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that its board of directors has appointed Donald A. Williams as a member of the bo
Read more →ATECAlphatec Holdings Announces First Quarter 2015 Revenue and Financial Results
CARLSBAD, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today financial results for the first quarter ended March 31, 2015. First quarter co
Read more →ATECAlphatec Spine to Release First Quarter 2015 Financial Results
CARLSBAD, Calif., April 17, 2015 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global medical device company that provides spinal fusion technology solutions for patients with spinal disorders, will release its first quar
Read more →ATECAlphatec Spine to Present at 10th Annual Canaccord Genuity Musculoskeletal Conference
CARLSBAD, Calif., March 10, 2015 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that the Company's President and Chief Executive Officer, Jim Corbett, will par
Read more →ATECAlphatec Holdings Announces Fourth Quarter and Full Year 2014 Revenue and Financial Results
CARLSBAD, Calif., Feb. 26, 2015 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today financial results for the fourth quarter and full year ended December 31, 2014.
Read more →ATECAlphatec Spine to Present at 35th Annual Cowen and Company Healthcare Conference
CARLSBAD, Calif., Feb. 18, 2015 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that the Company's President and Chief Executive Officer, Jim Corbett, will pres
Read more →ATECAlphatec Spine to Release Fourth Quarter and Fiscal Year 2014 Financial Results
CARLSBAD, Calif., Feb. 5, 2015 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global medical device company that provides spinal fusion technology solutions for patients with spinal disorders, will release its fourth quart
Read more →ATECAlphatec Spine to Present at Upcoming Investor Events in December 2014
CARLSBAD, Calif., Nov. 25, 2014 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that the Company's executives, Jim Corbett, President and Chief Executive Office
Read more →ATECAlphatec Spine Announces Appointment of Tom C. Davis to Its Board of Directors
CARLSBAD, Calif., Nov. 24, 2014 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that its board of directors has appointed Tom C. Davis as a member of the board
Read more →ATECAlphatec Spine to Participate in Upcoming Investor Events in November 2014
CARLSBAD, Calif., Nov. 5, 2014 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that the Company's executives, Jim Corbett, President and Chief Executive Officer
Read more →ATECAlphatec Holdings Announces Third Quarter 2014 Revenue and Financial Results
CARLSBAD, Calif., Oct. 30, 2014 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today financial results for the third quarter ended September 30, 2014. Third quarter
Read more →ATECAlphatec Spine to Showcase New Arsenal(TM) Spinal Fixation System at the Upcoming 29th Annual North American Spine Society (NASS) Meeting in San Francisco
CARLSBAD, Calif., Oct. 29, 2014 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that it will showcase its new spinal fixation system, Arsenal as well as its com
Read more →ATECAlphatec Spine to Release Third Quarter 2014 Financial Results
CARLSBAD, Calif., Oct. 15, 2014 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global medical device company that provides spinal fusion technology solutions for patients with spinal disorders, will release its third quart
Read more →ATECAlphatec Spine to Showcase Product Portfolio at EuroSpine 2014 in Lyon, France
CARLSBAD, Calif., Sept. 22, 2014 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today that it will showcase its product portfolio at the upcoming EuroSpine 2014 meet
Read more →ATECAlphatec Spine to Present at 34th Annual Canaccord Genuity Growth Conference
CARLSBAD, Calif., Aug. 5, 2014 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider or spinal fusion technologies, today announced it will present at the 34th Annual Canaccord Genuity Growth Conference on Wednesd
Read more →ATECAlphatec Holdings Announces Second Quarter 2014 Revenue and Financial Results
CARLSBAD, Calif., July 31, 2014 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, announced today financial results for the second quarter ended June 30, 2014. Second quarter co
Read more →ATECAlphatec Spine to Release Second Quarter 2014 Financial Results
CARLSBAD, Calif., July 17, 2014 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion technologies, will release its second quarter 2014 financial results on Thursday, July 31, 2014, after the clo
Read more →ATECAlphatec Spine to Present at Jefferies 2014 Global Healthcare Conference
CARLSBAD, Calif., May 19, 2014 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, today announced it will present at Jefferi
Read more →ATECAlphatec Holdings Announces First Quarter 2014 Revenue and Financial Results
CARLSBAD, Calif., April 30, 2014 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, announced today financial results for th
Read more →ATECAlphatec Spine Announces Executive Leadership Changes
James M. Corbett Named President, CEO and Board Member of Alphatec Effective May 1, 2014 Leslie H. Cross to Retire as Alphatec CEO; Will Continue as Chairman of the Board CARLSBAD, Calif., April 30, 2014 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent comp
Read more →ATECAlphatec Spine to Release First Quarter 2014 Financial Results
CARLSBAD, Calif., April 16, 2014 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, will release its first quarter 2014 fina
Read more →ATECAlphatec Holdings and OrthoTec, LLC Mutually Agree to Settle Ongoing Litigation
CARLSBAD, Calif., March 17, 2014 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, announced that it has entered into a bin
Read more →ATECAlphatec Holdings Announces Fourth Quarter and Full Year 2013 Revenue and Financial Results
CARLSBAD, Calif., March 17, 2014 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, announced today financial results for th
Read more →ATECAlphatec Spine Postpones Fourth Quarter and Fiscal Year 2013 Release and Conference Call
CARLSBAD, Calif., Feb. 20, 2014 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, announced today that it is postponing the
Read more →ATECAlphatec Spine Announces Jury Verdict in the OrthoTec Litigation
CARLSBAD, Calif., Feb. 11, 2014 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, announced today that a jury in the OrthoT
Read more →ATECAlphatec Spine to Release Fourth Quarter and Fiscal Year 2013 Financial Results
CARLSBAD, Calif., Feb. 10, 2014 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, will release its fourth quarter and fisca
Read more →ATECAlphatec Spine to Present at 24th Annual Oppenheimer Healthcare Conference
CARLSBAD, Calif., Nov. 25, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, today announced it will present at the 20
Read more →ATECAlphatec Spine to Present at 25th Annual Piper Jaffray Healthcare Conference
CARLSBAD, Calif., Nov. 19, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, today announced it will present at the 20
Read more →ATECAlphatec Spine Reports Third Quarter 2013 Financial Results
CARLSBAD, Calif., Nov. 7, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, today announced its financial results for
Read more →ATECAlphatec Spine Enters Into Collaboration Agreement With Group of Experienced Spine Surgeons
CARLSBAD, Calif., Oct. 24, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, today announced that it has entered into
Read more →ATECAlphatec Spine to Release Third Quarter 2013 Financial Results
CARLSBAD, Calif., Oct. 22, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, will release its third quarter 2013 finan
Read more →ATECAlphatec Spine to Showcase Comprehensive Product Portfolio at the Upcoming 28th Annual North American Spine Society (NASS) Meeting in New Orleans, Louisiana
CARLSBAD, Calif., Oct. 1, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, announced today that it will showcase seve
Read more →ATECAlphatec Spine to Showcase Product Portfolio at EuroSpine 2013 in Liverpool, UK
CARLSBAD, Calif., Sept. 25, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, announced today that it will showcase it
Read more →ATECAlphatec Spine Announces Restructured and Expanded Credit Facility
CARLSBAD, Calif., Sept. 16, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, announced today that it has amended its
Read more →ATECAlphatec Spine Announces Intent to Restructure Scient'x Business Operations
CARLSBAD, Calif., Sept. 16, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, announced that its French affiliate, Sci
Read more →ATECAlphatec Spine to Present at the Stifel Healthcare Conference, 2013
CARLSBAD, Calif., Aug. 28, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Announces Second Quarter 2013 Revenue and Financial Results
CARLSBAD, Calif., Aug. 6, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., announced today financial results for the second quarter of fiscal year 2013, ended June 30, 2013. Second Quarter 2013 Highlights Total revenue
Read more →ATECAlphatec Spine Announces Date for Release of Second Quarter 2013 Financial Results
CARLSBAD, Calif., July 25, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., today announced the following information for the release of its second quarter 2013 financial results and a conference call to discuss those res
Read more →ATECAlphatec Spine Postpones 2013 Annual Meeting of Stockholders to June 21, 2013 and Supplements Proxy Statement
CARLSBAD, Calif., June 11, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets physician-inspired solutions for patients with spinal disorders, today
Read more →ATECAlphatec Spine to Host Technology Day on June 6, 2013 in New York City
CARLSBAD, Calif., May 29, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets physician-inspired solutions for patients with spinal disorders, announc
Read more →ATECAlphatec Spine to Present at the Jefferies Global Healthcare Conference
CARLSBAD, Calif., May 21, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets physician-inspired solutions for patients with spinal disorders, announc
Read more →ATECAlphatec Spine to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
CARLSBAD, Calif., May 7, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets physician-inspired solutions for patients with spinal disorders, announce
Read more →ATECAlphatec Spine Announces First Quarter 2013 Revenue and Financial Results
CARLSBAD, Calif., April 30, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., announced today financial results for the first quarter of fiscal year 2013, ended March 31, 2013. "I am pleased to report strong results for A
Read more →ATECAlphatec Spine Announces Date for Release of First Quarter 2013 Financial Results
CARLSBAD, Calif., April 15, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., today announced the following information for the release of its first quarter 2013 financial results and a conference call to discuss those res
Read more →ATECAlphatec Spine to Present at the 2013 Canaccord/Genuity Musculoskeletal Conference in Chicago, IL on March 19, 2013
CARLSBAD, Calif., March 13, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company with a mission to provide physician-inspired solutions for patients with spinal disorders, today announced it will pres
Read more →ATECAlphatec Spine Receives FDA 510(K) Market Clearance for Its Alphatec Solus(TM) Internal Fixation Anterior Lumbar Interbody Fusion Device
CARLSBAD, Calif., March 12, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a company with a mission to provide physician-inspired solutions for patients with spinal disorders, announced today that the Company has receiv
Read more →ATECAlphatec Spine Announces Fourth Quarter and Full Year 2012 Revenue and Financial Results
CARLSBAD, Calif., Feb. 28, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., announced today financial results for the fourth quarter and fiscal year ended December 31, 2012. "On behalf of the entire global Alphatec Spine
Read more →ATECAlphatec Spine Announces Date for Release of Fourth Quarter and Full Year 2012 Financial Results
CARLSBAD, Calif., Feb. 12, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., today announced the following information for the release of its fourth quarter and full year 2012 financial results and a conference call to dis
Read more →ATECAlphatec Spine Receives U.S. FDA 510(K) Market Clearance for Two New Products and Receives Japanese Shonin Approval to Begin Marketing Its Novel(R) Peek Lumbar Spinal Spacers
CARLSBAD, Calif., Jan. 3, 2013 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine to Present at the 24th Annual Piper Jaffray Healthcare Conference
CARLSBAD, Calif., Nov. 15, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Completes Asset Acquisition of Irvine, CA-Based Phygen LLC
CARLSBAD, Calif., Nov. 7, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., announced today that it has closed its acquisition of certain assets of Phygen LLC. "We are very pleased and excited to close this important tran
Read more →ATECAlphatec Spine Announces Third Quarter 2012 Financial Results
CARLSBAD, Calif., Nov. 5, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., announced today financial results for the third quarter of fiscal 2012, ended September 30, 2012. "On behalf of the entire Alphatec Spine team, I
Read more →ATECAlphatec Spine Announces Date Change for Third Quarter 2012 Financial Results and Conference Call in Response to Aftermath of Hurricane Sandy
CARLSBAD, Calif., Oct. 31, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., announced today that due to the severe conditions on the East Coast as a result of Hurricane Sandy, the Company will delay its earnings release a
Read more →ATECAlphatec Spine Signs New Exclusive Supply Agreement for an Anchored, Zero-Profile Anterior Cervical Interbody Device
CARLSBAD, Calif., Oct. 23, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., announced today that the Company has signed a new supply agreement that provides the Company with exclusive worldwide rights to market, sell and
Read more →ATECAlphatec Spine to Showcase New Products at the Upcoming 27th Annual North American Spine Society (NASS) Meeting in Dallas, Texas
CARLSBAD, Calif., Oct. 23, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Announces Conference Call and Business Update in Advance of Attendance at the 27th Annual North American Spine Society (NASS) Meeting in Dallas, Texas
CARLSBAD, Calif., Oct. 22, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., announced today a conference call and live webcast, scheduled for today at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time, to provide a business
Read more →ATECAlphatec Spine Appoints New Senior Vice President of U.S. Commercial Operations
CARLSBAD, Calif., Oct. 4, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Receives Board Approval to Acquire Assets of Spine Implant Business
CARLSBAD, Calif., Sept. 27, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc. (the "Company"), announced today that its board of directors has approved the Company's plans to acquire certain assets of Phygen, LLC, a spinal
Read more →ATECAlphatec Spine Releases Alphatec NEXoss(TM) Nanostructure Bio-Active Matrix and Announces the First Patient Implant
CARLSBAD, Calif., Sept. 18, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus o
Read more →ATECAlphatec Spine to Present at the 2012 UBS Global Life Sciences Conference
CARLSBAD, Calif., Sept. 6, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Launches New MIS Device, the BridgePoint(TM) Spinous Process Fixation System
CARLSBAD, Calif., Aug. 23, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine to Present at the 2012 Stifel Nicolaus Health Care Conference
CARLSBAD, Calif., Aug. 23, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Announces Second Quarter 2012 Financial Results
CARLSBAD, Calif., Aug. 7, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., announced today financial results for the second quarter of fiscal 2012, ended June 30, 2012 "I am pleased to complete my first quarter as Alphat
Read more →ATECAlphatec Spine Appoints Luke T. Faulstick to Board of Directors
CARLSBAD, Calif., Aug. 7, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Announces Date for Second Quarter 2012 Financial Results
CARLSBAD, Calif., July 24, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a leading medical technology company involved in the design, development, manufacturing and marketing of products for the surgical treatment of s
Read more →ATECAlphatec Spine Announces New and Expanded Credit Facility
CARLSBAD, Calif., June 12, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine to Present at the Wells Fargo Securities 2012 Health Care Conference
CARLSBAD, Calif., June 7, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
CARLSBAD, Calif., May 11, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Announces First Quarter 2012 Revenue and Financial Results
CARLSBAD, Calif., May 8, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on t
Read more →ATECAlphatec Spine Announces Date for First Quarter 2012 Financial Results
CARLSBAD, Calif., April 24, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a leading medical technology company involved in the design, development, manufacturing and marketing of products for the surgical treatment of
Read more →ATECAlphatec Spine Appoints New Vice President of Operations
CARLSBAD, Calif., March 21, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus o
Read more →ATECAlphatec Spine to Present at the Cowen 32nd Annual Health Care Conference
CARLSBAD, Calif., March 1, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Announces Fourth Quarter and Full Year 2011 Revenue and Financial Results
CARLSBAD, Calif., Feb. 28, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Announces Management Realignment to Prepare Company for Next Phase of Global Growth
CARLSBAD, Calif., Feb. 28, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine to Attend Lazard Capital Management Medical Device Conference
CARLSBAD, Calif., Feb. 24, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Announces Date for Fourth Quarter and Full Year 2011 Financial Results
CARLSBAD, Calif., Feb. 14, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a leading medical technology company involved in the design, development, manufacturing and marketing of products for the surgical treatment of s
Read more →ATECAlphatec Spine to Present at the Canaccord Genuity Musculoskeletal Conference
CARLSBAD, Calif., Jan. 31, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Appoints New Senior Director of Investor Relations
CARLSBAD, Calif., Jan. 19, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine and Cross Medical Products Settle License Agreement Dispute
CARLSBAD, Calif., Jan. 5, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine to Present at the 23RD Annual Piper Jaffray Health Care Conference
CARLSBAD, Calif., Nov. 22, 2011 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Appoints New Vice President of Regulatory, Clinical Affairs and Quality
CARLSBAD, Calif., Nov. 16, 2011 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Appoints New Senior Vice President, Global Marketing and Asia Pacific
CARLSBAD, Calif., Nov. 16, 2011 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine to Present at the Lazard Capital Markets 8th Annual Healthcare Conference
CARLSBAD, Calif., Nov. 10, 2011 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Announces Third Quarter 2011 Revenue and Financial Results
Revenue of $47.6 million - 6.2% growth over Q3 2010 US revenue of $32.7 million; 8.9% growth over Q3 2010 Pro forma year to date revenue growth of 8.2%; Pro forma year to date US revenue growth of 11.4% Generated cash from operations of $1.8 million CARLSBAD, Calif., Nov. 1,
Read more →ATECAlphatec Spine Announces New Products at Upcoming North American Spine Society (NASS) Meeting in Chicago
CARLSBAD, Calif., Nov. 1, 2011 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine to Hold 3Q 2011 Financial Results Investor Call
CARLSBAD, Calif., Oct. 13, 2011 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a leading medical technology company involved in the design, development, manufacturing and marketing of products for the surgical treatment of s
Read more →ATECAlphatec Spine Announces Successful Resolution of FDA Warning Letter
CARLSBAD, Calif., Oct. 5, 2011 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine to Present at the Stifel Nicolaus Healthcare Conference 2011
CARLSBAD, Calif., Aug. 29, 2011 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Announces Second Quarter 2011 Revenue and Financial Results
Revenue of $50.9 million - 12.0% growth over Q2 2010; 7.6% growth on a constant currency basis US revenue of $34.5 million; 17.8% growth over Q2 2010 CARLSBAD, Calif., Aug. 4, 2011 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine,
Read more →ATECAlphatec Spine to Present at the 2011 Canaccord Genuity Growth Conference
CARLSBAD, Calif., Aug. 1, 2011 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Holdings, Inc. Names Leslie H. Cross Chairman of the Board of Directors
CARLSBAD, Calif., Aug. 1, 2011 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine, Inc. Comments on Untitled Letter Related to PureGen Osteoprogenitor Cell Allograft
CARLSBAD, Calif., July 25, 2011 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine, Inc. Receives Japanese Regulatory Shonin Approval for Illico SE(TM) Posterior Fixation Percutaneous Screw System for Minimally Invasive Surgery
CARLSBAD, Calif., July 18, 2011 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine to Hold 2Q 2011 Financial Results Investor Call
CARLSBAD, Calif., July 5, 2011 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a leading medical technology company involved in the design, development, manufacturing and marketing of products for the surgical treatment of sp
Read more →ATECAlphatec Spine to Present at the Jefferies 2011 Global Healthcare Conference
CARLSBAD, Calif., June 1, 2011 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Announces First Quarter 2011 Revenue and Financial Results
Revenue of $49.7 million; 40.8% growth over Q1 2010; Pro Forma revenue growth of 6.6% over Q1 2010; 5.2% Growth on a Constant Currency basis Adjusted EBITDA of $4.4 million Net Loss of $1.9 million, or ($0.02) per share and Non-GAAP Net Income of $0.1 million, or $0.00 per shar
Read more →ATECAlphatec Holdings Announces Appointment of Patrick Ryan as Chief Operating Officer
CARLSBAD, Calif., April 25, 2011 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures, and markets products for the surgical treatment of spine disorders, with a focus
Read more →ATECAlphatec Spine to Hold 1Q 2011 Financial Results Investor Call
CARLSBAD, Calif., April 21, 2011 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a leading medical technology company involved in the design, development, manufacturing and marketing of products for the surgical treatment of
Read more →ATECAlphatec Spine to Host Technology Day May 12, 2011 in New York, NY
CARLSBAD, Calif., April 13, 2011 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus o
Read more →ATECAlphatec Spine Receives 510(k) Clearance for Its Solus(TM) Anterior Lumbar Interbody Fusion System
CARLSBAD, Calif., April 4, 2011 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Announces the Addition of Leslie H. Cross to Its Board of Directors
CARLSBAD, Calif., March 29, 2011 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus o
Read more →ATECAlphatec Spine Announces Fourth Quarter and Full Year 2010 Revenue and Financial Results
Annual GAAP revenue of $171.6 million; 42.3% growth over 2009; pro forma revenue of $182.9 million; 7.1% growth over 2009 and 8.3% growth on a constant-currency basis Adjusted EBITDA of $18.9 million; 32.2% growth over 2009 CARLSBAD, Calif., Feb. 24, 2011 (GLOBE NEWSWIRE) -- Al
Read more →ATECAlphatec Spine to Present at the 2011 RBC Capital Markets Healthcare Conference
CARLSBAD, Calif., Feb. 23, 2011 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine to Hold 4Q 2010 Financial Results Investor Call
CARLSBAD, Calif., Feb. 16, 2011 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a leading medical technology company involved in the design, development, manufacturing and marketing of products for the surgical treatment of s
Read more →ATECAlphatec Spine, Inc. Announces the First Three-Level Guided Lumbar Interbody Fusion Procedure Performed Using the Revolutionary ARC(TM) Portal Access System
CARLSBAD, Calif., Jan. 4, 2011 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine to Present at the Piper Jaffray 22nd Annual Health Care Conference
CARLSBAD, Calif., Nov. 22, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Announces Third Quarter 2010 Revenue and Financial Results
Revenue of $44.8 million; 49% growth over 3Q 2009; Pro Forma Revenue Growth of 2% over 3Q 2009 and 2.3% Growth on a Constant-Currency Basis Adjusted EBITDA of $5.3 million; 11.9% growth over 3Q 2009 Non-GAAP Net Earnings of $0.7 million; or $0.01 per share CARLSBAD, Calif., No
Read more →ATECAlphatec Spine Appoints New Senior Vice President, Global Human Resources
CARLSBAD, Calif., Nov. 2, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Announces Debt Refinancing
CARLSBAD, Calif., Nov. 1, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine to Hold 3Q 2010 Financial Results Investor Call
CARLSBAD, Calif., Oct. 25, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a leading medical technology company involved in the design, development, manufacturing and marketing of products for the surgical treatment of s
Read more →ATECAlphatec Spine Announces Four New Product Launches in the MIS, Biologics and Thoracolumbar Market Segments at the North American Spine Society (NASS) Annual Meeting
CARLSBAD, Calif., Oct. 5, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures, and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine, Inc. Releases PureGen(TM) Osteoprogenitor Cell Allograft to Facilitate Bone Regeneration and Announces First Patient Procedure Performed in the World
CARLSBAD, Calif., Oct. 5, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Announces Second Quarter 2010 Revenue and Financial Results
Revenue of $45.4 Million; 55% Growth Over Q2 2009 Pro Forma Revenue Growth of 10% Over 2Q 2009 and 12.5% Growth on a Constant Currency Basis CARLSBAD, Calif., Aug. 5, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a
Read more →ATECAlphatec Spine to Present at the Canaccord Genuity 30th Annual Growth Conference 2010
CARLSBAD, Calif., Aug. 3, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine to Hold 2Q 2010 Financial Results Investor Call
CARLSBAD, Calif., July 20, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a leading medical technology company involved in the design, development, manufacturing and marketing of products for the surgical treatment of s
Read more →ATECAlphatec Spine to Present at Two Investor Conferences in June
CARLSBAD, Calif., June 7, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Announces First Quarter 2010 Revenue and Financial Results
CARLSBAD, Calif., May 10, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine to Present at the Ninth Annual JMP Securities Research Conference
CARLSBAD, Calif., May 6, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on t
Read more →ATECAlphatec Spine Adds New Vice President and General Manager, Latin America
CARLSBAD, Calif., May 5, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on t
Read more →ATECAlphatec Spine Appoints New Vice President of Clinical, Quality and Regulatory
CARLSBAD, Calif., May 4, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on t
Read more →ATECAlphatec Spine to Hold 1Q 2010 Financial Results Investor Call
CARLSBAD, Calif., April 29, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a leading medical technology company involved in the design, development, manufacturing and marketing of products for the surgical treatment of
Read more →ATECAlphatec Holdings Announces Completion of Public Offering of Common Stock and Full Exercise of Over Allotment Option
CARLSBAD, Calif., April 21, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus o
Read more →ATECCARLSBAD, Calif., 18 de Abril de 2010 (GLOBE NEWSWIRE) A Alphatec Holdings, Inc.
CARLSBAD, Calif., 18 de Abril de 2010 (GLOBE NEWSWIRE) A Alphatec Holdings, Inc. (Nasdaq:ATEC), a empresa-m e da Alphatec Spine, Inc., uma empresa de dispositivos m dicos que concebe, desenvolve, fabrica e comercializa produtos para o tratamento cir rgico de desordens da coluna,
Read more →ATECAlphatec Holdings Announces Pricing of Public Offering of Common Stock
CARLSBAD, Calif., April 16, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus o
Read more →ATECAlphatec Holdings Announces Proposed Public Offering of Common Stock
CARLSBAD, Calif., April 12, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus o
Read more →ATECAlphatec Spine Reports Preliminary First Quarter 2010 Revenues
CARLSBAD, Calif., April 12, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus o
Read more →ATECAlphatec Spine Completes Acquisition of Scient'x Groupe SAS
CARLSBAD, Calif., March 29, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus o
Read more →ATECAlphatec Spine Announces Stockholder Approval of Share Issuance Related to the Acquisition of Scient'x Groupe SAS
CARLSBAD, Calif., March 17, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus o
Read more →ATECAlphatec Spine to Host Technology Day April 23, 2010 8:30am -- 11:30am New York, NY
CARLSBAD, Calif., March 16, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus o
Read more →ATECAlphatec Spine Announces Expiration of Hart-Scott-Rodino Review Period for Acquisition of Scient'x Groupe S.A.S.
CARLSBAD, Calif., Feb. 25, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine to Present at Four Investor Conferences in March
CARLSBAD, Calif., Feb. 24, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Announces Fourth Quarter and Full Year 2009 Revenue and Financial Results
CARLSBAD, Calif., Feb. 23, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine to Hold 4Q 2009 and Full-Year 2009 Financial Results Investor Call
CARLSBAD, Calif., Feb. 4, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a leading medical technology company involved in the design, development, manufacturing and marketing of products for the surgical treatment of sp
Read more →ATECAlphatec Spine Receives CE Mark for its OsseoScrew(TM) Spinal Fixation System and Its GLIF/ ARC(TM) Portal Access System
CARLSBAD, Calif., Feb. 2, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures, and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine, Inc. Enters Into Exclusive Distribution Agreement With Parcell Spine, LLC
CARLSBAD, Calif., Jan. 13, 2010 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Agrees to Acquire Scient'x Groupe SAS
CARLSBAD, Calif., Dec. 17, 2009 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine to Present at the Piper Jaffray 21st Annual Health Care Conference
CARLSBAD, Calif., Nov. 19, 2009 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
CARLSBAD, Calif., Nov. 10, 2009 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Announces Third Quarter 2009 Revenue and Financial Results
CARLSBAD, Calif., Nov. 9, 2009 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine, Inc. Enters Supply and Distribution Agreement With ETEX Corporation for Novel Biologics Products
CARLSBAD, Calif., Nov. 5, 2009 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine to Host Investor Community Breakfast During the North American Spine Society Annual Meeting
CARLSBAD, Calif., Oct. 30, 2009 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine to Hold 3Q 2009 Financial Results Investor Call
CARLSBAD, Calif., Oct. 26, 2009 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a leading medical technology company involved in the design, development, manufacturing and marketing of products for the surgical treatment of s
Read more →ATECAlphatec Spine Announces Key Activities At 2009 American Academy of Orthopedic Surgeons Annual Meeting
Market Launch of Anterior Lumbar Interbody Fusion System Full Commercial Release of VIP of OsseoFix+ Cement System and VIP Aging Spine Marketplace Overview by Industry Expert Robin Young CARLSBAD, Calif., Feb. 24, 2009 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC),
Read more →ATECAlphatec Spine Licenses New Technology to Treat Lumbar Spinal Stenosis
CARLSBAD, Calif., Feb. 23, 2009 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine to Present At the Canaccord Adams Musculoskeletal Conference
CARLSBAD, Calif., Feb. 17, 2009 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine to Hold 4Q and Year End 2008 Financial Results Investor Call
CARLSBAD, Calif., Feb. 17, 2009 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a leading medical technology company involved in the design, development, manufacturing and marketing of products for the surgical treatment of s
Read more →ATECAlphatec Spine to Present At Rodman & Renshaw and Lazard Capital Markets Healthcare Conferences
CARLSBAD, Calif., Nov. 5, 2008 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Announces Third Quarter 2008 Revenue and Financial Results
CARLSBAD, Calif., Nov. 3, 2008 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Expands European Presence; Names Peter Kohlbecher as Vice President, General Manager - Europe
CARLSBAD, Calif., Oct. 31, 2008 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Appoints Siri S. Marshall, Esq. to Its Board of Directors
CARLSBAD, Calif., Oct. 29, 2008 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine to Announce Third Quarter 2008 Financial Results
CARLSBAD, Calif., Oct. 27, 2008 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a leading medical technology company involved in the design, development, manufacturing and marketing of products for the surgical treatment of s
Read more →ATECAlphatec Spine Launches www.agingspinecenter.com -- Web-Based Portal for Healthcare Providers and Patients
CARLSBAD, Calif., Oct. 14, 2008 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a leading medical technology company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, wit
Read more →ATECAlphatec Spine Reports Preliminary Record Third Quarter 2008 Revenues; Provides Increased Revenue Guidance; Updates OsseoFix Development Status; Unveils 'Solutions for the Aging Spine' Brand and Launches Nine New Products
CARLSBAD, Calif., Oct. 13, 2008 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Announces Scheduled Company Update and Conference Call
CARLSBAD, Calif., Oct. 10, 2008 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on
Read more →ATECAlphatec Spine Launches New Orthobiologics Product - ProFUSE Bone Scaffold Packaged in Proprietary Vacuum Infusion Packaging System
CARLSBAD, Calif., Oct. 7, 2008 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a leading medical technology company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with
Read more →ATECAlphatec Spine Announces 510(k) Clearance for Its Novel Cervical Interbody Implant
CARLSBAD, Calif., Sept. 25, 2008 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a leading medical technology company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, wi
Read more →ATECAlphatec Spine to Present At the UBS Global Life Sciences Investor Conference
CARLSBAD, Calif., Sept. 16, 2008 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company involved in the design, development, manufacturing and marketing of products for the surgical treatment of spine disord
Read more →ATECAlphatec Spine to Present At Canaccord Adams and Noble Financial Investor Conferences
CARLSBAD, Calif., Aug. 11, 2008 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company involved in the design, development, manufacturing and marketing of products for the surgical treatment of spine disorde
Read more →ATECAlphatec Spine Announces Second Quarter 2008 Revenue and Financial Results
CARLSBAD, Calif., Aug. 4, 2008 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company involved in the design, development, manufacturing and marketing of products for the surgical treatment of spine disorder
Read more →ATECAlphatec Spine to Announce Second Quarter 2008 Financial Results
CARLSBAD, Calif., July 30, 2008 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a leading medical technology company involved in the design, development, manufacturing and marketing of products for the surgical treatment of s
Read more →ATECAlphatec Spine's OsseoFix Clinical Study Initiated
CARLSBAD, Calif., July 24, 2008 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a leading medical technology company involved in the design, development, manufacturing and marketing of products for the surgical treatment of s
Read more →ATECAlphatec Holdings, Inc. Announces Sales Launch in Europe
CARLSBAD, Calif., June 6, 2008 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced that its subsidiary,
Read more →ATECAlphatec Holdings, Inc. Announces Planned Management Transition
CARLSBAD, Calif., May 9, 2008 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today that Steven Yas
Read more →ATECAlphatec Holdings, Inc. Reaches Successful Settlement and Release Agreement to License Pedicle Screw Technology
CARLSBAD, Calif., May 7, 2008 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today that it has rea
Read more →ATECAlphatec Holdings, Inc. Announces Record First Quarter 2008 Revenue and Financial Results
CARLSBAD, Calif., April 24, 2008 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today financial results and re
Read more →ATECAlphatec Holdings, Inc. Terminates License for DYNAMO Semi Rigid Rod System
CARLSBAD, Calif., April 24, 2008 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today that Alphatec and Sc
Read more →ATECAlphatec Holdings, Inc. Announces Webcast and Conference Call to Review Q1 2008 Results
CARLSBAD, Calif., April 10, 2008 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, will conduct a webcast and confe
Read more →ATECAlphatec Holdings, Inc. Names Veteran Executive Mitsuo Asai President of Alphatec Pacific, Inc.
CARLSBAD, Calif., April 3, 2008 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today that veteran
Read more →ATECAlphatec Holdings, Inc. Names Veteran Sales and Marketing Executive Gary Fredericks Vice President of Corporate Accounts
CARLSBAD, Calif., April 2, 2008 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today that seasoned
Read more →ATECAlphatec Holdings, Inc. Acquires a Worldwide License for Innovative Expandable Interbody/Vertebral Body Replacement Technology
CARLSBAD, Calif., March 13, 2008 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spinal disorders, announced that the company's wholly
Read more →ATECAlphatec Holdings, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Revenue and Financial Results
CARLSBAD, Calif., Feb. 13, 2008 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today financial results and rec
Read more →ATECAlphatec Holdings, Inc. Names Veteran Spinal Orthopedics Executive J.P. Timm as Vice President of Research and Development
CARLSBAD, Calif., Feb. 11, 2008 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today that veteran
Read more →ATECAlphatec Holdings, Inc. Acquires An Exclusive Worldwide License for Innovative Dynamic Anterior Cervical Plate Technology
CARLSBAD, Calif., Feb. 6, 2008 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spinal disorders, announced that the company's wholly o
Read more →ATECAlphatec Holdings, Inc. Appoints Executives Rohit M. Desai and Dirk Kuyper to Its Board of Directors
CARLSBAD, Calif., Feb. 5, 2008 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today that Rohit M. Desa
Read more →ATECAlphatec Holdings, Inc. Announces Webcast and Conference Call to Review Q4 2007 Results
CARLSBAD, Calif., Feb. 5, 2008 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, will conduct a webcast and confere
Read more →ATECAlphatec Holdings, Inc. Announces the Commercial Introduction of Its Unique DYNAMO Semi-Rigid Spinal System
CARLSBAD, Calif., Jan. 16, 2008 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, today announced that its unique DYNAMO(tm
Read more →ATECAlphatec Holdings, Inc. Names Leading Biomechanics Executive Andrew Mahar as Senior Director of Biomechanics and Clinical Research
CARLSBAD, Calif., Jan. 15, 2008 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today that veteran
Read more →ATECAlphatec Holdings, Inc. Acquires an Exclusive Worldwide License for Innovative Pedicle Screw Technology
CARLSBAD, Calif., Dec. 20, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spinal disorders, announced the entry into an exclusiv
Read more →ATECAlphatec Holdings, Inc. Announces Revenue Guidance for Fiscal Year 2008
CARLSBAD, Calif., Dec. 13, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, today announced revenue guidance for the
Read more →ATECAlphatec Holdings, Inc. Announces Webcast and Conference Call to Review Fiscal Year 2008 Outlook and Revenue Guidance
CARLSBAD, Calif., Dec. 11, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, will conduct a webcast and confer
Read more →ATECAlphatec Holdings, Inc. to Present at Upcoming Conferences
CARLSBAD, Calif., Nov. 28, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, will attend the 2007 BMO Capital Markets
Read more →ATECAlphatec Holdings, Inc. Receives FDA 510(k) Clearance for the ZODIAC LUXE 4.0 Millimeter Diameter Pedicle Screw
CARLSBAD, Calif., Nov. 19, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today that it has received
Read more →ATECAlphatec Holdings, Inc. Receives FDA 510(k) Clearance For the DYNAMO Rod System
CARLSBAD, Calif., Oct. 25, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today that it has received
Read more →ATECAlphatec Holdings, Inc. Announces Record Revenue and Third Quarter 2007 Financial Results
CARLSBAD, Calif., Oct. 23, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today financial results and rec
Read more →ATECAlphatec Holdings, Inc. to Present At Upcoming Conference
CARLSBAD, Calif., Oct. 22, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, will attend the CIBC World Market
Read more →ATECAlphatec Holdings, Inc. Announces Webcast and Conference Call to Review Q3 2007 Results
CARLSBAD, Calif., Oct. 22, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, will conduct a webcast and confer
Read more →ATECAlphatec Holdings, Inc. Announces Exercise of Option to Purchase Additional Shares
CARLSBAD, Calif., Sept. 25, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced that Canaccord Adams Inc.,
Read more →ATECAlphatec Holdings, Inc. Announces Pricing of Common Stock Offering
CARLSBAD, Calif., Sept. 21, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced the pricing of its public
Read more →ATECAlphatec Holdings, Inc. Acquires An Exclusive Worldwide License for Technology Related to Guided Lumbar Interbody Fusion System
CARLSBAD, Calif., Sept. 13, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced the entry into an exclusiv
Read more →ATECAlphatec Holdings, Inc. Names Veteran Marketing Executive Kathryn Liljestrand as Vice President of Marketing
CARLSBAD, Calif., Sept. 13, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today that veteran marketi
Read more →ATECAlphatec Holdings, Inc. Names Veteran Operations Executive Kermit P. Stott as Vice President of Operations
CARLSBAD, Calif., Sept. 10, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today that veteran
Read more →ATECAlphatec Holdings, Inc. to Participate in 57th Annual 2007 Congress of Neurological Surgeons Meeting
CARLSBAD, Calif., Sept. 7, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, will attend the 2007 Congress
Read more →ATECAlphatec Holdings, Inc. Announces Second Quarter 2007 Financial Results and Plans to Improve Overall Cost Structure, While Continuing to Invest in Opportunities for Sustained Profitable Growth
CARLSBAD, Calif., Aug. 6, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today financial results for the
Read more →ATECAlphatec Holdings, Inc. Announces Webcast and Conference Call to Review Q2 2007 Results, Monday, August 6, 2007 at 1:30 p.m. PT / 4:30 p.m. ET
CARLSBAD, Calif., July 25, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, will conduct a webcast and confer
Read more →ATECAlphatec Holdings, Inc. Appoints Mortimer Berkowitz III Chairman of the Board of Directors
CARLSBAD, Calif., July 20, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today that Mortimer Ber
Read more →ATECAlphatec Holdings, Inc. Announces Webcast and Conference Call to Review Q2 2007 Results
CARLSBAD, Calif., July 18, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, will conduct a webcast and confer
Read more →ATECAlphatec Holdings, Inc. Appoints Prominent Spine Surgeon Frank P. Cammisa Jr., M.D. to Scientific Advisory Board
CARLSBAD, Calif., June 28, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today that noted orthop
Read more →ATECAlphatec Holdings, Inc. Expands Its Spinal Disorder Solution Technology With the Launch of the New NOVEL-TL Spinal Spacer System
CARLSBAD, Calif., June 20, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today the release of th
Read more →ATECAlphatec Holdings, Inc. Names Veteran Spinal Orthopedic Industry Executive Dirk Kuyper as President and Chief Executive Officer
CARLSBAD, Calif., June 6, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today that veteran ortho
Read more →ATECAlphatec Holdings, Inc. Drives Spinal Disorder Solution Technology and Announces the Launch of the New CONNECT II Cervical Structural Allograft Product
CARLSBAD, Calif., May 15, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today the release of the
Read more →ATECAlphatec Holdings, Inc. Appoints James R. Glynn to Board of Directors
CARLSBAD, Calif., May 1, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today that James R. Glynn
Read more →ATECAlphatec Holdings, Inc. Announces First Quarter 2007 Financial Results
CARLSBAD, Calif., April 26, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today financial results for th
Read more →ATECAlphatec Holdings, Inc. Announces Webcast and Conference Call to Review Q1 2007 Results Thursday, April 26, 2007 At 2:00 p.m. PT / 5:00 p.m. ET
CARLSBAD, Calif., April 23, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, will conduct a webcast and confe
Read more →ATECAlphatec Holdings, Inc. Licenses Technology Focused On Minimally Invasive Spinal Surgery Market
CARLSBAD, Calif., April 12, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today that it has ente
Read more →ATECAlphatec Holdings, Inc. Enhances Technology and Product Portfolio With Global Licensing Agreement
CARLSBAD, Calif., April 11, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today that it has ente
Read more →ATECAlphatec Holdings, Inc. Announces Japanese Ministry's Approval of Its NOVEL Titanium Product Family
CARLSBAD, Calif., March 29, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today that its NOVEL(r
Read more →Competitive Position
How ATEC ranks across every disease it competes inCompetitive Position is a premium feature
See how ATEC ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial